
































An Investigation into the Molecular Targets Mediating 
Cannabidiol Action in the Free-living Ciliate Tetrahymena 
pyriformis 
Nathan Tims 
Student ID: 35358571 
Under the Supervision of Dr. Jackie Parry & Dr. Karen Wright 
A Thesis Submitted in Fulfilment of the 
Requirements for the Degree of  







The Author would like to declare that this thesis has been composed solely by himself and that 
the work within was performed only by himself, without collaboration, unless specifically 
indicated. This thesis has not been submitted in fulfilment of any other degree scheme or 
qualification at this or any other institution. Many of the ideas providing the basis for this work 
were produced through discussion with supervisors Dr. Jackie Parry & Dr. Karen Wright. 
 




























Table of Contents.  
Glossary ………………………………………………………………………………………...  
Abstract ………………………………………………………………………………………...  
 
Chapter 1: Introduction ………………………………………………………………………. 
1.1. The human endocannabinoid system (ECS)  ……………………………………………………….. 
1.1.1 Cannabinoids – ligands of the ECS ……………………………………………………………   
  1.1.1.1. Endogenous cannabinoids …………………………………………………………………  
  1.1.1.2. Phytocannabinoids ………………………………………………….……………………..  
1.1.2 Synthesis and degradation of endogenous cannabinoids ……………………………………...  
  1.1.2.1.Anabolic enzymes …………………………………………………………………………. 
  1.1.2.2. Catabolic enzymes  ……………………….………………………………………………. 
1.1.3. Cannabinoid receptors and signaling ………………..……………………………………….. 
  1.1.3.1. Cannabinoid receptor 1 – CB1 ……………………………………….…………………… 
  1.1.3.2. Cannabinoid receptor 2 – CB2 ……………………………………………………………. 
  1.1.3.3. GPR55 …………………………………………………………………………………….. 
  1.1.3.4. TRP channels ……………………………………………………………………………… 
1.2. Evidence for an ECS in protists ……………………………………………………………………... 
1.2.1. General overview of protists ………………………………………………………..………… 
1.2.2 Effect of cannabinoids on Tetrahymena behaviour ……………………………………………. 
1.2.3. Presence of FAAH and MAGL in Tetrahymena ……………………………………...………. 
1.2.4. Presence of endocannabinoids in Tetrahymena ………………………………………...…….. 
1.2.5. Cannabinoid receptors in Tetrahymena ………………………………………………..……… 
  1.2.5.1. G protein-coupled receptors (GPCRs) …………………………………………………….. 
    1.2.5.1.1. Opioid receptor ……………………………………………………………………......... 
    1.2.5.1.2. Dopamine receptors ……………………………………………………………….......... 
    1.2.5.1.3. Serotonin (5-HT) receptors ……………………………………………………………... 
    1.2.5.1.4. Adenosine receptors (ARs) ……………………………………………………………... 
    1.2.5.1.5. Orphan GPCRs …………………………………………………………………………. 
  1.2.5.2. Peroxisome proliferator-activated receptors (PPARs) …………………………………….. 
































1.3. The Ciliate feeding mechanism ………………………………………………………………………………….  
    1.3.1. Prey Capture ………………………………………………………………………………....……  
    1.3.2. Prey Recognition …………………………………………………………………………….........  
      1.3.2.1. C-type lectin receptors (CLRs) ……………………………………………………………......  
      1.3.2.2. Scavenger Receptors (SRs) …………………………………………………………………… 
    1.3.3. Food vacuole formation ………………………………………………………………………......  
    1.3.4. Food vacuole maturation/digestion ……………………………………………………………….  
    1.3.5. Defecation and food vacuole membrane recycling ……………………………………………….   
1.4. Conclusion and aims …………………………………………………………………………………..  
Chapter 2. Materials and Methods …………………………………………………………….. 
2.1. Cell/microsphere maintenance and preparation ……………..………………………………………..  
     2.1.1. Tetrahymena pyriformis ………………………………………………………………………….  
     2.1.2. Klebsiella aerogenes ……………………………………………………………………………..  
     2.1.3. Live Synechococcus sp. ………………………………………………………………………….  
     2.1.4. Heat killed (dead) DTAF-stained Synechococcus sp …………………………………………….  
     2.1.5. Fluorescently Labelled Microspheres ……………………………………………………………  
2.2. Cell/Beads counts …………………………………………………………………………………….. 
     2.2.1. Determining T. pyriformis concentration …………………………………………….…………. 
     2.2.2. Determining Synechococcus sp./bead concentration ……………………………………………. 
     2.2.3. Counting prey inside T. pyriformis cells ………………………………………………………… 
 2.3. Experimental compounds ……………………………………………………………………………. 
     2.3.1. Cannabidiol (CBD) ………………………………………………………………………………  
     2.3.2. C-type lectin receptor (CLR) and scavenger receptor (SR) blockers …………………………… 
     2.3.3. Other antagonists/receptor blockers …………………………………….………………………..  
2.4. Effect of CBD concentration on T.pyriformis feeding ……………………………………..………….  
2.5. Effect of blocking T. pyriformis receptors on its feeding behaviour ………………………………….  
     2.5.1. Preliminary toxicity experiments …………………………………………………………………  
     2.5.2. Blocking receptors (other than CLRs and SRs) ………………………………………………….  
2.5.3. Blocking C-type lectin receptors (CLR) and Scavenger Receptors (SRs) ………………………….  
     2.5.3.1 Experiments devoid of CBD – CLRs and SRs ………………………………………………….  
     2.5.3.2. Experiments involving CBD – CLRs only …………………………………………….……….  




































Chapter 3. Results ………………………………………………………………………….……. 
3.1. The Effect of CBD Concentration on T.pyriformis feeding ……………………………………………  
3.2. Toxic effects of antagonists/blockers on T.pyriformis …………………………………………………  
3.3. The effect of blocking receptors and components of the MAPK pathway ……………………………. 
3.4. The effect of blocking C-type lectin receptors (CLRs) and scavenger receptors (SRs) ……………….  
     3.4.1. Effect on T.pyriformis feeding in the absence of CBD …………………………………………… 
       3.4.1.1. Effect of prey type ……………………………………………………………………………..  
       3.4.1.2. Blocking CLRs …………………………………………………………………………….......  
       3.4.1.3. Blocking SRs …………………………………………………………………………………..  
     3.4.2. Effect on T.pyriformis feeding in the presence of CBD …………………………………………..  
Chapter 4. Discussion …………………………………………………………………………….  
4.1. Summary of Results …………………………………………………………………………………….  
4.2. T.pyriformis feeding in the absence of CBD ……………………………………………………………  
     4.2.1. Receptor involved in the uptake of live, dead, and inert prey by T.pyriformis ……………………  
     4.2.2. Interaction between Synechococcus and the receptors …………………………………………….  
       4.2.2.1. Mannose and the mannose receptor ……………………………………………………………  
       4.2.2.2. GalNAc and the GalNAc receptor …………………………………………………………….  
       4.2.2.3. GlcNAc and the GlcNAc receptor ……………………………………………………………..  
       4.2.4.4. Interaction with Scavenger receptors …………………………………………………………..  
4.3. The effect of CBD on T.pyriformis feeding …………………………………………………………….  
     4.3.1. The CBD-Induced feeding lag …………………………………………………………………….  
       4.3.1.1. MIC and duration ………………………………………………………………………………  
       4.3.1.2. CBD targets for induction of feeding lag ………………………………………………………  
       4.3.1.3. Ending the feeding lag …………………………………………………………………………  
     4.3.2. T. pyriformis feeding post the CBD-induced lag period ………………………………………….  
4.4. Potential Cellular targets of CBD in T.pyriformis ……………………………………………………..  
     4.4.1. Targets involved in T.pyriformis feeding …………………………………………………………  
     4.4.2. Other cellular targets of CBD …………………………………………………………………….  
       4.4.2.1. Cilia – movement and feeding …………………………………………………………….......  





































Chapter 5. Conclusion ………………………………………………………………………...  
Acknowledgments …………………………………………………………………………….. 
Appendix ……………………………………..…………………………………......................   
Bibliography …………………………………………………………………………………..  
 





































2-AG             
2-OG             
2-PG              
5-HT             
5-HTR         
AA                
AEA              
AR                 
Ar-DAG        
ARP               
BG 11 
BPA              
cAMP 
CB1/2            
CBC               
CBD               
CBN                     
CLR 
CNS               
ConA              
COX              
CS                   
CTLD             
DA            
DAGL α/β      
DCAR             
DC-SIGN        
 
DOR              
DRP 
DS 
DTAF                   
ECS                
EEA                           
ERK 1/2 










Actin related protein 
Blue Green 11 
Bauninia purpurea agglutinin 
Cyclic adenosine monophosphate 




C-type lectin receptor 
Central nervous system 
ConcanavalinA 
Cyclooxygenase 
Chondroitin sulphate  
C-type lectin like domains 
Dopamine 
Diacylglycerol lipase α/β 
Dendritic cell immune activating receptor 
Dendritic cell-specific intercellular adhesion molecule-3-grabbing  
non-integrin 
Delta opioid receptor 
Dynamin related protein 
Dextran sulphate 
 5-(4,6-dichlorotriazinyl) aminofluorescein 
Endocannabinoid system 
N-eicosenoylethanolamine 
Extracellular signal regulated kinase 1/2 









FV                   
GalLR             
GalNAc           
GlcLR             
GlcNAc     
GlyR 
GPCR             
IR                   
JNK                 
KOR                                
LB                   
LEA                
LPS                 
LTA                
LOX               
MAA               
MAG              
MAGL            
MAPK            
MCL               
MEK               
MIC 
MLR               
MOR              
MPA 
MurNAc              
NAE             
NADPH 
NAGly            
NAPE             
NAPE-PLD    
NArPE            
NAT                
OEA  
OxLDL           
PAMP             
PAP                 
Food vacuole 
N- acetylgalactosamine lectin receptor 
N- acetylgalactosamine   
N-acetylglucosamine lectin receptor 
N-acetylglucosamine   
Glycine Receptor  
G protein coupled receptor 
Ingestion Rate  
c-Jun N-terminal kinase 






Maakia amurensis agglutinin 
Monoacylglycerol  
Monoacylglycerol lipase  
Mitogen activated protein kinase  
Macrophage C-type lectin    
MAPK/extracellular regulated signal kinase kinase 
Minimum inhibitory concentration 
Mannose lectin receptor  
Mu opioid receptor 
Maclura pomifera agglutinin  
N-acetylmuramic acid 
N-acylethanolamine 
Nicotinamide adenine dinucleotide phosphate  
N-arachidonylglycine 
N-acylphosphatidylethanolamine  




Oxidised low-density lipoproteins 
Pathogen associated molecular pattern               









PEA                 
PG-EA            
PG-GE            
PI3P                
PLC                 
PNA                 
PP                    
PPAR              
PPRE              
PRR  
PTM                                            
SBA 
SEA                 
SR                    
TRPA/M/V     
UM                  
VAMP 
V-ATPase 
VGCC             
VFF                 
VFR                 
VPT                 
WGA               

















Prostaglandin glycerol ethanolamines 





Peroxisome proliferator activated receptor 
PPAR-responsive regulatory elements 
Pattern recognition receptor 
Post translation modification 
Soy bean agglutinin 
N-stearoylethanolamine 
Scavenger receptor  
Transient receptor potential ankyrin/melastatin/vanilloid 
Undulating membrane 
Vesicle associated membrane protein 
ATP-dependent vacuolar protein pump 
Voltage gated calcium channel 
Vacuole formation factor  
Vacuole formation rate 
Vacuole passage time 






This study aimed to characterised the effect of cannabidiol (CBD) on the feeding behaviour of 
Tetrahymena pyriformis and to determine its molecular target(s). Experiments involved feeding T. 
pyriformis with a Synechococcus sp. prey (live or dead) or latex beads, in the presence/absence of CBD 
with/without the pre-blocking of specific receptors or components of the MAPK pathway. CBD caused a 
reduction in ingestion rate (IR) at ca. 2 µM until it was zero at ≥2.5 µM and this gave rise to a feeding 
lag. The lag was temporary, with its duration being positively correlated to CBD concentration. Post-lag, 
the ciliate began to feed again, and the resulting IR correlated positively with the duration of the lag; 
reflecting the satiation level of the ciliate, as food vacuoles continued to be defecated during this feeding 
lag. A feeding lag of >32 min, with the defecation of ca. 3 food vacuoles, induced ‘starvation’ in T. 
pyriformis and this resulted in the ciliate exhibiting hyperphagia.  
The role of feeding receptors (C-type lectins [CLRs] and Scavenger Receptors [SRs]) in this CBD 
response was evaluated. T. pyriformis utilised SRs and CLRs for mannose, N-acetylglucosamine 
(GlcNAc), and N- acetylgalactosamine (GalNAc) for the ingestion of live Synechococcus, which were 
ingested at higher rates, and gave rise to more food vacuoles, than dead cells/beads. Heat-treatment 
destroyed the mannose, GlcNAc and SR ligands on Synechococcus cells, leaving only GalNAc residues to 
facilitate the uptake of dead cells. None of the receptors were involved in the uptake of beads. The 
blocking of these receptors, prior to adding CBD, did not abolish the CBD-induced feeding lag but post-
lag IRs were not hyperphagic; being equivalent to that expected when blocking these receptors in the 
absence of CBD. This suggests that these receptors do not directly interact with CBD. The blocking of 
other receptors (GCPRs and TRPV, PPAR, Dopamine, Serotonin and Adenosine), which are known to 
interact with CBD in other eukaryotic cells, was also tested but none abolished the CBD-induced feeding 
lag, suggesting that T. pyriformis has few, if any, CBD-interacting receptors that are associated with its 
feeding mechanism. The ciliate also did not perceive CBD as an external stress as no evidence of 
activation of the MAPK pathway was recorded. It was therefore proposed that the target(s) of CBD, for 
reducing IR, might be vacuole formation/membrane recycling (which would prevent the development of 
nascent food vacuoles) and/or ciliary function (which would reduce swimming speed and the formation of 
feeding currents in the oral cavity); both of which involve actin, microtubules, and dynein.  
The mechanism behind the action of CBD on T. pyriformis feeding is more complicated than first 
thought, but with its considerably reduced repertoire of potential targets, compared to human cells, 
elucidating its targets, and whether these are evolutionary conserved, might be achievable. It is hoped that 
the knowledge gleaned will aid in the future implementation of CBD as an effective therapeutic agent for 
a number of conditions.  
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Chapter 1. Introduction  
 
1.1 The human endocannabinoid system (ECS) 
The human endocannabinoid system (ECS) is responsible for mediating a broad range of 
neuromodulatory effects which include not only central-nervous-system (CNS) related processes such as 
memory, brain development, cognition and pain reception (Fernández-Ruiz et al., 2000; Alger, 2013; 
Pacher and Kunos, 2013) but also processes in more peripheral systems such as immunity, reproduction, 
digestion and inflammation (Maccarrone et al., 2015).  
The ECS itself is a lipid based signalling system encompassing endogenous cannabinoid ligands 
(endocannabinoids) (see 1.1.1.1), cannabinoid receptor 1 and 2 (CB1 and CB2) (see 1.1.3.1 & 1.1.3.2) 
and the anabolic and catabolic enzymes involved in cannabinoid metabolism (see 1.1.2.1 & 1.1.2.2) (Lu 
and Mackie, 2016). Mediators of the ECS are extremely promiscuous and crosstalk between the ECS and 
other systems is common and forms what has been termed an ‘endocannabinoidome’ (Di Marzo and 
Piscitelli, 2015). As a result, the ECS is implicated in a range of diseases and its near ubiquity makes it an 
attractive therapeutic target in almost all diseases (Pacher et al., 2006; Pacher and Kunos, 2013). 
 
1.1.1 Cannabinoids – ligands of the ECS 
Cannabinoids are long chain, lipid based signaling molecules defined by their binding to cannabinoid 
receptors (Fonseca et al., 2013). Cannabinoids can either be produced endogenously (Endocannabinoids) 
or be plant derived (Phytocannabinoids). 
 
1.1.1.1 Endogenous cannabinoids 
The first endocannabinoid discovered in a mammalian brain was Anandamide/N-arachidonoyl 
ethanolamide (AEA) (Fig. 1.1.) (Devane et al., 1992). AEA is a member of the N-acylethanolamines 
(NAEs) and is a partial agonist of CB1 and CB2 (Gómez-Ruiz et al., 2007) with greater CB1 affinity than 
CB2 (Fonseca et al., 2013). The second endocannabinoid, 2-arachidonoyl-glycerol (2-AG) (Fig. 1.1.), 
belongs to the monoacyl glycerol (MAG) family and was first isolated from canine gut (Sugiura et al., 
1995). 2-AG appears to have a much greater binding affinity for CB1 and CB2 than AEA and is present 
in higher concentrations. Furthermore, 2-AG is a full agonist of both CB1 and CB2, unlike AEA (Gómez-
Ruiz et al., 2007). Both AEA and 2-AG are present in the CNS and periphery although 2-AG is found in 
higher concentrations in both (Fonseca et al., 2013). 
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There are also ‘endocannabinoid like’ compounds which are additional endogenous MAGs and NAEs. 
They share similar metabolizing enzymes to AEA and 2-AG and are able to modulate cannabinoid 
binding, but are not typically CB1/2 ligands (Fonseca et al., 2013; Kleberg et al., 2014). The two best 
understood examples are the NAEs N-oleoyethanolamine (OEA) and N-palmitoylethanolamine (PEA) 
(Fig. 1.1.) which share the same ethanolamine group as AEA. OEA and PEA bind less strongly to CB1 




Phytocannabinoids are derived from Cannabis sativa and over 140 have been isolated to date (Elsohly et 
al., 2017). Δ9- tetrahydrocannabinol (Δ9-THC) (Fig. 1.1.) is the main psychoactive component of C. sativa 
and was the first phytocannabinoid isolated and characterised (Gaoni and Mechoulam, 1964). THC is one 
of the few phytocannabinoids known to be a partial agonist for both CB1 and CB2 along with Δ8-THC 
and cannabinol (CBN) (Di Marzo and Piscitelli, 2015; Aizpurua-Olaizola et al., 2017). THC and THC-
derivatives have been investigated for their therapeutic potential and have shown promise in some areas 
such as in anti-convulsant, analgesic or anti-inflammatory effects (Lastres-Becker et al., 2005; Pacher et 
al., 2006; Mouhamed et al., 2018) although it’s therapeutic use is limited by its psychoactive effects 
(Shevyrin and Morzherin, 2015). 
Cannabidiol (CBD) (Fig. 1.1.) is the main non-psychoactive cannabinoid found in C. sativa and has been 
widely investigated for its therapeutic effects in a range of diseases (Devinsky et al., 2014; Chye et al., 
2019). CBD has an impressive safety profile with minimal adverse effects and no psychoactive properties 
Figure 1.1. 
Structures of the two primary 
phytocannabinoids cannabidiol (CBD) 
and Δ9-Tetrahydrocannabinol (THC), the 
two primary endocannabinoids: 
anandamide and 2-Arachidonoylglycerol 
and the two primary endocannabinoid-like 
compounds: Oleoylethanolamide and 
Palmitoylethanolamide 
Figure adapted from Pacher et al., 2020 
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(Iffland and Grotenhermen, 2017) making it an attractive therapy. Unlike THC, it only exhibits very low 
CB1/2 affinities with studies suggesting it can actually act as a negative allosteric regulator of CB1 
(Laprairie et al., 2015; Tham et al., 2019). CBD is also known to have the ability to inhibit the activity of 
Fatty acid amide hydrolase (FAAH), a degradative enzyme of NAEs (see 1.1.2.2) and can somewhat 
inhibit the cellular uptake of AEA (Bisogno et al., 2001; De Filippis et al., 2008). CBD has been 
suggested to act upon over 65 molecular targets in humans (Bih et al., 2015). The amount of evidence for 
this activity differs between targets and, as a result, the clarity of CBD effects on many of these targets is 
poorly understood (Bih et al., 2015). Therefore, further research into these additional molecular targets is 
required to help elucidate the therapeutic potential of CBD. 
1.1.2 Synthesis and degradation of endogenous cannabinoids 
1.1.2.1. Anabolic enzymes 
Synthesis of endocannabinoids occurs on demand which is unlike classic neurotransmitters which are 
stored and released when required (Lutz, 2004). AEA synthesis utilises the membrane bound 
phospholipid N-arachidonyl-phosphatidylethanolamie (NArPE), a type of N-acyl-
phosphatidylethanolamine (NAPE) (Fig. 1.2, A). NArPE is synthesised using N-acyltransferase (NAT) 
via the transfer of arachidonic acid (AA) from phosphatidylcholine onto phosphatidylethanolamine 
(Cadas et al., 1996). In the primary route of AEA production, NArPE is hydrolysed via a NAPE specific 
Phospholipase D (NAPE-PLD) to release AEA (Schmid et al., 1983). Three alternative NAPE-PLD 
independent pathways have also been elucidated (Fig. 1.2, A) (Liu et al., 2006; Simon and Cravatt, 2006; 
2008). 
The synthesis of 2-AG involves a much simpler two step reaction beginning with the production of 2-
arachidonoyl containing diacylglycerols (Ar-DAGs) from membrane bound glycerophospholipids by one 
of two reactions: 1) Hydrolysis of phosphoinositides, by a specific PLCβ or 2) The hydrolysis of 
phosphatidic acid via phosphatidic acid phosphohydrolase (PAP) (Fig. 1.2, B). The resulting Ar-DAG is 
hydrolysed by diacylglycerol lipase α or β (DAGL α/β) to produce 2-AG (Gómez-Ruiz et al., 2007; 
Muccioli, 2010). Two less characterised pathways have also been suggested for 2-AG synthesis although 
2-AG seems to be produced chiefly via the DAGL mediated pathway (Fig 1.2, B) (Ueda et al., 2011; 





Figure 1.2. Synthesis and inactivation of the primary endocannabinoids Anandamide and 2-ararchidonyl-glycerol. Thicker black 
arrows denote the primary pathway of synthesis and degradation. 
Abbreviations: Abh4, αβ hydrolase 4; ABH6 & 12, αβ hydrolase 6 & 12; AEA, Anandamide; COX2, Cyclooxygenase 2; CYPs, Cytochrome 
P450s; DAG, Diacylglycerol; DAGL, Diacylglycerol Lipase; EET-EA, epoxyeicosatrienoic acid ethanolamide; FAAH, Fatty acid amide 
hydrolase; GDE-1, Glycerophosphodiesterase 1; GP-AEA, Glycerophosphoanandamide; HETEs, hydroxy-eicosatetraenoic acids; HEET-EAs, 
hydroxylated epoxyeicosatrienoic acid ethanolamides; HETE-EAs, hydroxy eicosatetraenoic acid ethanolamides; LOXs, lipoxygenases; LPA, 
Lysophosphatidic acid; Lyso-PLC, lysoPI phospholipase C; Lyso-PLD, Lysophospholipase D; MAGL, Monoacylglycerol lipase; NAT, N-
acyltransferase; NAPE-PLD, N-acyl phosphatidylethanolamine phospholipase D; N-ArPE, N-arachidonyl-phosphatidylethanolamine; p-AEA, 
Phosphoanandamide; PAP, Phosphatidic acid phosphohydrolase; PG-EA, Prostaglandin ethanolamine; PG-EG, prostaglandin glycerol ester; 
PLA1, Phospholipase A1; PLC, Phospholipase C; PTPN22, Protein tyrosine phosphatase, non-receptor type 22; 2-Ar PI, 2-arachidonoyl-lyso 






















1.1.2.2. Catabolic enzymes 
Hydrolysis is the primary route of degradation for all NAEs and MAGs including AEA and 2-AG (Fig 
1.2). Hydrolysis of AEA cleaves the amide bond to release AA and ethanolamine. The primary enzyme 
involved in NAE hydrolysis is fatty acid amide hydrolase (FAAH) (Deutsch and Chin, 1993), a 
membrane bound serine hydrolase particularly active in brain tissue (Hillard et al., 1995) (Fig. 1.2, A). 
Mice deficient in FAAH showed drastically increased levels of AEA in the brain along with increase pain 
reduction (associated with CB1 stimulation) demonstrating the FAAH catabolic role (Cravatt et al., 2001). 
A second isomer of FAAH (FAAH-2) is also present in several other mammals including primates and 
humans. This isomer is localised to lipid droplets and shares 20% sequence identity with FAAH-1 (Wei et 
al., 2006). Substrate specificity between isomers is similar with both acting upon NAEs although FAAH-




For 2-AG, hydrolysis of its ester bond releases AA and glycerol (Fig. 1.2, B). The primary enzyme 
involved is Monoacylglycerol Lipase (MAGL), a cytosolic serine hydrolase abundant in brain tissue 
coexpressed with CB1 receptors (Gómez-Ruiz et al., 2007; Fonseca et al., 2013). Two closely related 
isoforms have been identified in rats, 35 and 37kDa in size (Dinh et al., 2002). MAGL is the primary 
source of 2-AG degradation accounting for ~85% of 2-AG hydrolysis (Blankman et al., 2007). Two other 
membrane integral enzymes, ABH6 and 12, also contributed significant hydrolysis activity (~4% and 9% 
respectively) (Blankman et al., 2007). Together, MAGL, ABH6 and ABH12 account for ~98% of 2-AG 
hydrolysis in the brain (Blankman et al., 2007). The remaining activity is thought to be due to a range of 
serine hydrolases, including FAAH (Goparaju et al., 1998). 
Enzymatic oxidation is a secondary method of degradation and mainly serves to create substrates for 
eicosanoid biosynthesis, mediated by Lipoxygenases (LOXs) (Fig. 1.2). Several types of LOX enzymes, 
such as 15-LOX, 12-LOX variants from both plants and mammals, have been shown to oxidise the AA 
unit of endocannabinoids (Rouzer and Marnett, 2011). Cyclooxygenases (COX) have 2 human isoforms 
and studies have shown that COX-2, but not COX-1, is able to oxidise 2-AG and AEA to prostaglandin 
glycerol esters (PG-GE) and prostaglandin glycerol ethanolamines (PG-EA) (Kozak et al., 2000; Kozak et 
al., 2002). Cytochrome P450 enzymes, of which there are 57 known human variants, have also 
demonstrated the ability to oxidise some endocannabinoids to epoxyeicosatrienoic acids (Zelasko et al., 
2015). Although AEA is metabolized by a much wider range of P450 enzymes compared to 2-AG, both 
have demonstrated significant degradation via this mechanism (Zelasko et al., 2015). 
 
1.1.3 Cannabinoid receptors and signaling 
Endocannabinoid signalling occurs in a retrograde fashion (Fonseca et al., 2013; Di Marzo and Piscitelli, 
2015). Endocannabinoids themselves are synthesised in post-synaptic terminals and released into the 
synaptic cleft where they bind presynaptic membrane bound cannabinoid receptors (Fonseca et al., 2013; 
Di Maezo and Piscitelli, 2015). There are two true classical cannabinoid receptors, CB1 and CB2, and 
two more recently accepted cannabinoid receptors (GPR55 and Transient Receptor Potential [TRP] 
channels) (Pacher et al., 2020). Typically, endocannabinoids induce a suppressive effect, with the 
endocannabinoid induced depolarization of the pre-synaptic terminal resulting in both transient and long-







1.1.3.1. Cannabinoid receptor 1 - CB1 
Early research revealed that cannabinoids acted via inhibiting cyclic adenosine monophosphate (cAMP) 
synthesis in a pertussis toxin sensitive manner (a bacterial toxin that inhibits Gi, Go and Gt receptor 
interactions) (Howlett et al., 1986; Howlett et al., 1988) suggesting a G protein-coupled receptor (GPCR)-
mediated signalling event. CB1 was the first to be identified in humans and was characterised as a 472 
amino acid GPCR coupled to an adenylate cyclase mechanism (Gérard et al., 1991). Distribution was 
mostly in the brain and it was also seen to share a 97.3% sequence identity with a previously identified 
murine receptor (Gérard et al., 1991). 
CB1 brain distribution is conserved across mammals (Iannotti et al., 2016) and can be used to explain the 
effects of cannabinoids. For example, distribution in the forebrain and cerebellum may explain 
cannabinoid effect on cognition and movement and the lesser distributions of CB1 in medullary nuclei 
(which control respiratory and cardiovascular responses) could explain the relatively high safety profile of 
CBD (Herkenham et al., 1990; Iannotti et al., 2016). Conversely, CB1 peripheral expression is 
heterogenous and varies between excitatory (glutamatergic) and inhibitory (GABAergic) synapses, seeing 
more distribution in the latter (Kano, 2014). CB1 also exhibits expression beyond the brain being found in 
most peripheral tissues including smooth and skeletal muscle, adipose, heart, skin, GI tract and bone 
(Iannotti et al., 2016).  
CB1 is chiefly expressed in the plasma membrane as is typical for GPCRs, although, a separate 
subpopulation has intracellular localisation in endosomes, lysosomes, and mitochondrial membranes (Zou 
and Kumar, 2018). CB1 is coupled primarily with Gi/o proteins and activation can have a variety of 
downstream effects: 1) Inhibition of adenylate cyclase (this being the primary pathway). 2) Activation of 
Mitogen activated protein kinases (MAPKs). 3) inhibition of voltage gated Calcium channels. 4) 
activation of inwardly rectifying K+ currents (Fig 1.3.). Several other proteins beyond Gi/o have also 
demonstrated CB1 interaction, including the alternative G proteins Gs and Gq, although Gi/o still remains 
the primary protein (Howlett et al., 2010; Kano, 2014). 
1.1.3.2. Cannabinoid receptor 2 – CB2 
The second cannabinoid receptor, CB2, exhibits expression primarily in macrophages of the marginal 
zone of the spleen (Munro et al., 1993). It consists of a 360 amino acid protein and shares 44% sequence 
identity with CB1 (Zou and Kumar, 2018). CB2 seems to be less conserved between species with the 
human and rodent CB2 having only 80% sequence identity compared to the CB1’s 97.3% (Zou and 
Kumar, 2018). CB2 binding specificities also differ from CB1 with CB2 demonstrating lower affinity for 




The primary cannabinoid induced signal transduction 
mechanisms. Cannabinoid agonism of a cannabinoid 
receptor (CD1/2) causes activation of the 
heterodimeric Gi/o protein leading to dissociation of 
the alpha and beta/gamma subunits.  
Green lines indicate activation whereas black lines 
indicate inhibition.  
AC, Adenylate cyclase; cAMP, cyclic AMP; ERK, 
Extracellular signal related kinase AKA MAP kinase; 
GIRK, G protein coupled inwardly rectifying K+; PKa,, 
Protein Kinase A; VSCC, Voltage gated Ca2+ channel.  
(Gómez-Ruiz et al., 2007) 
et al., 1993; Zou and Kumar, 2018). CB2 also couples with Gi/o proteins but does not couple with Gs and 
Gq proteins unlike CB1, yet it still demonstrates very similar downstream effects (Fig 1.3.) (Kano, 2014; 
















CB2 is primarily expressed in cells of the immune system (Graham et al., 2010; Zou and Kumar, 2018). 
Moderate/high levels are found in monocytes, NK cells, B-lymphocytes and low levels found in CD4/8+ T 
lymphocytes cells suggesting that the ECS plays a large role in modulating the immune system (Graham 
et al., 2010). Expression is also seen in other organs of the immune system such as the spleen and tonsils 
but also in some other peripheral tissues including the heart, GI tract and reproductive system, albeit it in 
small quantities (Zou and Kumar, 2018). Very small quantities can also be found in the brain (Gong et al., 
2006). With its presence in the immune system, CB2 is thought to play a role in immune system 
modulation with roles in regulation of inflammation, control of cytokine and lymphangiogenic factor 
release, and immune cell migration (Iannotti et al., 2016). Furthermore, despite its small quantity in the 
brain, CB2 is still thought to play a role in neuroinflammation due to its presence in activated astrocytes 
and microglial cells (Ashton and Glass, 2007; Benito et al., 2008). 
1.1.3.3. GPR55 
GPR55 is a 319 amino acid GPCR located in several tissues including the spleen, intestine, fetal and some 
regions of the brain (Sawzdargo et al., 1999). GPR55 exhibits coupling to Gq or G12 alpha subunits and 
triggers the release of Ca2+ from intracellular stores via a Gq, PLC (Phospholipase C) or G12, RhoA 
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signaling pathway (Lauckner et al., 2008). It shares very little general amino acid sequence identity with 
CB1 (13.5%) and CB2 (14.4%) and binds most potently with an endogenous lysophospholipid 
(lysophosphatidylinositol) which is now thought to be its natural ligand (Oka et al., 2007). However, it 
can bind AEA, 2-AG, THC and CBD also (Ryberg et al., 2007; Lauckner et al., 2008). And, unlike CB1 
and CB2 which exhibit highly conserved sequences in their ligand binding regions, this is not the case for 
GPR55 (Petitet et al., 2006).  
1.1.3.4. TRP channels 
Transient receptor potential (TRP) channels are a collection of trans-membrane, cation selective ion 
channels comprised of 4 subunits each containing 6 transmembrane helices (Caterina, 2014). Channels 
undergo homo or heterodimerization to form a functional pore (Caterina, 2014; Muller et al., 2019). 
Every cell expresses at least one subtype of TRP channel and so they are implicated in a diverse array of 
metabolic functions including sensation of pain, temperature and itching, cardiovascular function, 
neurotransmitter release and immune function (Caterina, 2014; Muller et al., 2019). There are 28 known 
TRP channels but cannabinoids are only known to modulate 6 members from 3 subfamilies: TRP 
vanilloid (TRPV 1-4), TRP ankyrin (TRPA 1), and TRP melastatin (TRPM 8) (Muller et al., 2019). The 
most well documented, with regards to interactions with cannabinoids, is TRPV1 which is a calcium 
channel whose natural ligand is capsaicin (Caterina, 2014). AEA, OEA, PEA, 2-AG, cannabichromene 
(CBC) and CBD have been shown to act as agonists for TRPV1  
 
1.2.  Evidence for an ECS in protists 
 
1.2.1. General overview of protists 
Protists are a heterogenous and ubiquitous collection of microbial eukaryotic organisms belonging to the 
domain Eukarya (Fenchel and Finlay, 2004; Foissner, 2008). Protist classification is difficult due to their 
immense diversity, but in brief, they encompass 3 broad groups: the protozoa (heterotrophic protists), 
algae and slime molds (Foissner, 2008). Protists are ubiquitous and are cosmopolitan in distribution, 
being able to grow wherever their habitat requirements are met (Fenchel and Finlay, 2004; Finlay and 
Fenchel, 2004; Foissner, 2008). In each environment, they play an important role as key producers and 
consumers in food chain (Pernthaler, 2005; Caron et al., 2012). For example, the ‘microbial loop’ 
describes how bacteria incorporate dissolved organic matter into their biomass which is then transferred 
to the next trophic level upon their consumption by protists (Azam et al., 1983). These protists also 
contribute significantly to nutrient regeneration through the release of dissolved nutrients, mainly 
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orthophosphate and ammonium (Sherr et al., 1983; Dolan, 1997), which can be used by their bacterial and 
algal prey (Caron et al., 1988; Kirchman, 1994). Their grazing pressure is also known to be a primary 
factor shaping the composition of bacterial and algal communities (Pernthaler et al., 1996; Macek et al., 
1997). 
Protists show diversity in metabolism, with heterotrophic, phototropic and mixotrophic protists all being 
common (Yaeger, 1996; Corliss, 2002). Within the heterotrophic protozoa, there are ciliates, amoeba and 
flagellates with the majority being ubiquitous, free-living organisms, although parasitic or endosymbiotic 
examples are present (Yaeger, 1996; Corliss, 2002). Their size generally ranges between 2 µm - 2000µm 
with most flagellates being < 2 µm, most amoebae < 20 µm and most ciliates < 200 µm (Finlay and 
Esteban, 1998). The three groups use different methods for locomotion and feeding (Yaeger, 1996; 
Corliss, 2002). Amoeba use their flexible cell shape to create cellular extensions called pseudopodia 
which are used for locomotion on surfaces and phagocytosis of prey in a similar fashion to macrophages 
(Geisen et al., 2018; Diaz and Laybourne-Parry 2019). Flagellates utilise flagella for motility and feeding, 
e.g. choanoflagellates use flagella to create a water current that pulls prey into a collar of prior to 
engulfment with pseudopodia (Caron et al 2012; Geisen et al., 2018; Diaz and Laybourne-Parry, 2019). 
The ciliates utilise cilia for feeding and locomotion with the majority being ‘filter feeders’, i.e., using cilia 
to pull water towards the cytostome (cell mouth) from which they can ‘filter’ out prey particles (Verni 
and Gualtieri, 1997; Caron et al., 2012; Geisen et al., 2018; Diaz and Laybourne-Parry, 2019). Their rate 
of bacterial consumption is extremely high, especially within the ciliates (Fenchel, 1982; Sherr and Sherr, 
2007), and most information regarding the protozoan feeding mechanism has been gathered for this 
protozoan group.  
There are a small number of studies which have examined either the behaviour of protists in the presence 
of cannabinoids or sought evidence for the presence of individual ECS components in their cells. To date, 
a complete picture of a protist ECS does not exist but the most comprehensive information has 
undoubtedly been gathered for the ciliate Tetrahymena (T. thermophila and T. pyriformis). 
  
1.2.2. Effect of cannabinoids on Tetrahymena behaviour 
Δ9-THC has been shown to elicit a transient dose dependent response on T. pyriformis cell shape and 
motility, with cells becoming ovoid, sluggish and irregular in their movement (McClean and Zimmerman, 
1976). The cells also showed delays in cell division and an overall reduction in the number of cells 
dividing, along with a decrease in nucleic acids synthesis (McClean and Zimmerman, 1976). A later study 
confirmed that the THC-induced delay in cell division occurred in the G2 phase of the cell cycle and was 
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attributed to a THC-mediated suppression of cyclic AMP and GMP production; levels of which normally 
fluctuate and control ciliate cell division (Zimmerman et al., 1981).  
More recently, Wanlahbeh (2020) showed that CBD and AEA induced cell death in a T. pyriformis 
population (MICs of 3.16 and 1.17 µM, respectively), with the population recovering in ~90 minutes. 
Jaisswar (2020) also showed that CBD and AEA (at 4 µM) immediately halted feeding in T. pyriformis 
for 60 and 36 min, respectively, and when feeding resumed AEA-treated cells fed at the same rate as the 
Control cells whereas CBD-treated cells had elevated ingestion rates (hyperphagia). Further work 
revealed that neither CBD nor AEA halted food vacuole processing and defecation in T. pyriformis which 
led to the suggesting that the cannabinoid target was a factor involved in the initial recognition and uptake 
of prey by the ciliate (Jaisswar 2020).  
1.2.3. Presence of FAAH and MAGL in Tetrahymena 
T. pyriformis has been shown to possess two FAAH isoforms (tFAAH), i.e., a 66kDa membrane isoform 
and a 45kDa cytosolic form (Karava et al., 2005). These are of similar size to the 63-67kDa mammalian 
FAAH (Giang and Cravatt, 1997), and the 46kDa invertebrate FAAH (Matias et al., 2001). tFAAH is 
secreted from the ciliate cell and exhibits high activity particularly against AEA; 90% of AEA was 
hydrolysed to AA within 5 minutes of administration (Karava et al., 2001). The resulting AA was 
incorporated mostly into phospholipids and, to a lesser extent, into non-polar lipids (Karava et al., 2001). 
Although tFAAH is considered specific for AEA, under alkaline conditions the T. pyriformis supernatant 
could also hydrolyses OEA and PEA, suggesting this orthologue can have multiple NAE substrates, as 
has been recorded for the mammalian counterpart (Karava et al., 2001).  
T. thermophila possesses two MAGL isoforms (tMAGL), i.e, a membrane active 45kDa protein and a 
cytosolic 40kDa protein (Evagorou et al., 2010). These are larger than the two isoforms identified 
mammals (35 and 37 kDa) (Dinh et al., 2002). Both ciliate isoforms are involved in the hydrolysis of 2-
AG and 2-Oleoylglycerol (2-OG) and they have similar optimum conditions to the MAGL in mammals, 
i.e., optimum pH of 8-9 and temperature of 37-40oC (Evagorou et al., 2010).  
1.2.4. Presence of endocannabinoids in Tetrahymena 
To date, no endocannabinoid synthesizing enzymes have been identified in Tetrahymena and yet, 
Anagnostopoulos et al., (2010) discovered a suite of endocannabinoids in T. thermophila which included 
NAEs, 2-AcGs and free fatty acids.  
With regards to the NAEs, the 6 most common were N-γ-linolenoylethanolamine (GLEA), N-
eicosenoylethanolamine (EEA), N-linoleoylethanolamine (LEA), N-palmitoylethanolamine (PEA), N-
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oleoylethanolamine (OEA) and N-stearoylethanolamine (SEA). AEA was identified but at low 
concentrations (Anagnostopoulos et al., 2010). Although common within the T. thermophila cell, GLEA, 
SEA and EEA are very rare in nature (Anagnostopoulos et al., 2010; Kleberg at al., 2014; Gaitán et al., 
2018), while LEA, PEA and OEA are more common and are found primarily in the GI tract (Artmann et 
al., 2008). All NAEs were hydrolyzed by FAAH, with the highest enzyme activity being evident with 
AEA, followed by LEA and GLEA (Anagnostopoulos et al., 2010).  
1.2.5. Cannabinoid receptors in Tetrahymena 
Although Tetrahymena possesses endocannabinoids, and the enzymes that metabolise them, a 
cannabinoid receptor has yet to be identified. A de novo phylogenetic analysis of functional orthologues 
of some known receptors strongly suggested that Tetrahymena does not possess CB1, CB2 TRPV1 and 
GPR55 (McPartland et al., 2006), however, there are other lesser known receptors which have been 
shown to interact with endocannabinoids, phytocannabinoids and/or synthetic cannabinoids, and which 
are putatively present in Tetrahymena (Table 1.1). Thus, one or more of these might be acting as the 
cannabinoid receptor in Tetrahymena.    
1.2.5.1. G protein-coupled receptors (GPCRs) 
Considering the classical endocannabinoid receptors, CB1 and 2, are both GPCRs it is considered likely 
that cannabinoids interact with a GPCR in Tetrahymena. Indeed, a variety of GPCRs are now considered 
as putative endocannabinoid receptors (see 1.1.3.3).  
1.2.5.1.1. Opioid receptor  
Tetrahymena possess the ability to produce and respond to a range of hormones which can influence 
cellular function, particularly phagocytosis (Csaba, 2012; 2017). For example, the opioid β-endorphin, 
when applied exogenously, can stimulate a chemotactic effect in Tetrahymena (O'Neill et al., 1988) and 
inhibit phagocytosis (Salaman et al., 1990; Chiesa et al., 1993). Tetrahymena spp. can produce β-
endorphin-like peptides which also antagonise phagocytosis (Renaud et al., 1995; Rodriguez et al., 2004). 
This inhibitory effect appears to be mediated by an opioid receptor homologue (O'Neill et al., 1988), 
which is a GPCR exhibiting Gi/o linkage (Benarroch, 2012), and which appears to be most similar to the µ 
(MOR) class of opioid receptors (Chiesa et al., 1993).  
Although no endogenous cannabinoid has yet been shown to interact with opioid receptors, work on 
murine models revealed that the phytocannabinoids CBD and THC exhibit allosteric modulation of 
MORs with both exhibiting negative regulation (Vaysse et al., 1987; Kathmann et al., 2006). The 
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synthetic cannabinoid receptor agonist ‘rimonabant’ also exhibits allosteric modulation of MORs despite 
being structurally unrelated to CBD or THC (Cinar and Szücs, 2009).  
Table 1.1. Some known receptors and the traditional cannabinoids and cannabinoid like compounds that interact 
with them.  a, McPartland (2006b); b, Pertwee et al (2010); c, Turner et al (2017); d, Muller et al (2019); e, 
Zygmunt et al, (2013); f, O’Sullivan (2016); g, De Duve and Baudhuin (1996); h, Bih et al (2015); i, Ciliate.org; j, 
Laun et al (2019); k, Kohno et al (2006), L, Chiesa et al (1993), m, Ud-daula (2012), n, Csaba (2012), o, Baig and 
Ahmad (2016) 
Receptor Classic cannabinoid and 
cannabinoid-like ligands  
Evidence for their presence in 
Tetrahymena sp. 
Cannabinoid receptor 1 & 2. 
(CB1 & 2) 
AEA b, 2-AG b, THC b No a 
TRPV1 AEA b,d, PEA b,d, OEA b,d, 2-
AG e, CBD b,d 
No a  
PPAR AEA, PEA, OEA, 2-AG, 
CBD, THC h f 
None identified currently but 
peroxisomes are present g 
Adenosine receptors  
 
AEA b, 2-AG b, CBD c,h No 
Serotonin (5-HT) AEA b, THC b, CBD c,h 
 
Tetrahymena are able to 
produce and respond to 




AEA & 2-AG to Nicotinic, 
only AEA to muscarinic b, 
CBD to Nicotinic h 
 
No, but muscarinic receptors 
are present in some protists o 
Opioid  
 
THC b, CBD h  
Yes, µ (MOR)-like receptor. 
Interactions with a variety of 
opioids is also possible L 
Dopamine  No classical cannabinoids 
exhibit binding yet but some 
synthetic cannabinoids haveb 
Yes. D1 like-receptorm 
GPR55 AEA b, 2-AG b, THC b,c, CBD 
c,h 
No a 
GPR 3, 6, 12 
 
CBD j GPR6 only i 
GPR18 
 






1.2.5.1.2. Dopamine receptors  
Tetrahymena can synthesize and react to catecholamines, with dopamine being considered the primary 
catecholamine present in its cells (Csaba, 2012; 2015). Endogenous dopamine effects have been 
suggested to differ from those in higher eukaryotes (Gundersen and Thompson, 1985) but the actual effect 
is still unknown. However, levels are known to fluctuate between stationary and logarithmic growth 
stages suggesting a potential role in cell growth (Goldman et al., 1981) 
In humans, dopamine acts upon two families of GPCR dopaminergic receptors, i.e., D1-like receptors 
(encompassing D1 and D5), and D2-like receptors (encompassing D2, D3 and D4) (Mishra et al., 2018).  
D1-like receptors couple primarily to the Gs family of G proteins (Gs and Golf), whereas D2-like receptors 
couple primarily to the Gi/o family (Mishra et al., 2018). Previous work has shown that  Δ9-THC can bind 
directly to D1 receptors (Miyamoto et al., 1996) while CBD binds to, and acts as a partial agonist of D2 
receptors (Seeman, 2016). AEA can also be an antagonist of D2 receptors which is thought to play 
regulatory roles in dopamine-induced behaviours (Beltramo et al., 2000). 
A D1-like receptor has been identified in T. thermophila although the authors did not rule out the possible 
presence of a D2-like receptor as well (Ud-Daula et al., 2012).  
1.2.5.1.3. Serotonin (5-HT) receptors  
Tetrahymena is known to synthesize and respond to serotonin (Csaba, 2015) with the main response 
being a stimulation of phagocytosis (Quiñones-Maldonado and Renaud, 1987). In humans, serotonin 
mediates its effects via diverse families of 5-HT receptors (5-HTRs) of which there are seven subclasses 
(5-HT 1-7) (Bockaert et al., 2010). 5-HTRs are GPCRs that are linked with Gi/o, Gq/11 and Gs alpha 
subunits (Bockaert et al., 2010; Masson et al., 2012). 5-HT1A is the receptor that has been shown to 
mediate serotonin-induced stimulation of phagocytosis in macrophages (Freire-Garabal et al., 2003) and it 
has also been shown to interact directly with CBD (Rock et al., 2012; Pazos et al., 2013; Fogaça et al., 
2014; Sonego et al., 2016; De Gregorio et al., 2019). 5-HT1A,B,D,E and 5-HT2C receptors can also interact 
directly with AEA, which inhibits binding to 5-HT to these receptors (Pertwee et al., 2010). 
No 5-HT analogue has been found in Tetrahymena or other protists to date. However, Al-Hammadi 
(2020) found that the negative action of CBD on phagocytosis in the amoeba Naegleria gruberi was 
abolished in the presence of (S)-WAY 100135, which is a specific 5-HT1A blocker, suggesting the 





1.2.5.1.4. Adenosine receptors 
Adenosine is present in Tetrahymena and used for metabolism of its phosphate linked derivatives 
(Voichick et al., 1973), but little work has been done on the physiological effects of adenosine itself. 
Adenosine receptors (ARs) belong to the GPCR family and are divided into 4 subtypes: A1, A2A, (both of 
which display high adenosine affinity) A2B, and A3A (displaying low adenosine affinity) with A1 and A3A 
exhibiting Gi/o coupling while A2A and A2B exhibit Gs/olf coupling (Sheth et al., 2014). Human 
macrophages and monocytes both possess A1 or A2 receptors, with stimulation either increasing or 
inhibiting phagocytosis depending on temporal factors relating to the timeline of monocyte differentiation 
into macrophages (Haskó et al., 2007). ARs have demonstrated some limited interactions with CBD in 
mammalian models (Castillo et al., 2010; Mecha et al., 2013). The antiarrhythmic properties of CBD were 
shown to be abolished through the use of an A1 antagonist (Gonca and Darıcı, 2015) and evidence also 
showed that CBD anti-inflammatory effects may partially be mediated through A2A (Castillo et al., 2010; 
Mecha et al., 2013). Furthermore, AEA and 2-AG have both been shown to be negative allosteric 
inhibitors of human A3 receptors but not A1 receptors (Lane et al., 2010). 
No AR analogue has been found in Tetrahymena or other protists to date. 
1.2.5.1.5. Orphan GPCRs 
Orphan GPR3, 6 and 12 belong to a family of GPCRs that bind Sphingosine-1 phosphate (Uhlenbrock et 
al., 2002). They exhibit 60% sequence similarity with each other and 40% similarity with CB1/2 (Morales 
et al., 2018). They exhibit coupling to either Gi/o or Gs which inhibit and activate adenylate cyclase, 
respectively (Uhlenbrock et al., 2002; Pertwee et al., 2010). Endogenous agonists for all 3 are yet to be 
confirmed and hence why they are termed ‘orphan’ (Morales et al., 2018). Neither AEA nor 2-AG 
demonstrate significant activity at any of the three GPRs (Yin et al., 2009; Laun et al., 2019), whereas 
CBD has been shown to demonstrate significant agonism for the trio (Laun et al., 2019).  
GPR18 is an 331 amino acid orphan GPCR and studies suggest that N-arachidonylglycine (NAGly), a 
carboxylic metabolite of AEA, is its endogenous ligand which, upon binding, activates coupled Gi/o 
proteins (Gantz et al., 1997). In addition, some evidence is present suggesting AEA, 2-AG and synthetic 
CBD analogues can activate GPR18 (Kohno et al., 2006; McHugh et al., 2010). 
GPR119 is another orphan GPR which is 335 amino acids in length and shares little sequence identity 
with other known GPRs (Fredriksson et al., 2003). The receptor exhibits coupling to a Gs protein-
adenylate cyclase based mechanism (Ritter et al., 2016). Ligands with the highest affinity for GPR119 are 
fatty acid amides, particularly OEA (present in Tetrahymena), which has been proposed as the primary 
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orthosteric ligand of GRP119 (Overton et al., 2006). AEA, PEA and SEA (present in Tetrahymena) can 
also act as slight agonists although not to the same degree as OEA (Overton et al., 2006).  
Only relatively recently has a GPR6 homologue been found in T. thermophila via a study utilising the 
Tetrahymena genome database (Lampert et al., 2011). This Tetrahymena GPR6 possessed the closest 
sequence similarity with a GPCR from several plants and the ciliate Paramecium and seems to be 
involved with Tetrahymena chemotaxis (Lampert et al., 2011). A second orphan GPCR was identified in 
T. thermophila by (Lampert et al.,2011b), i.e., GPR37 which shared the greatest sequence similarities 
with a known GPCR from Dictyostelium and with the T. thermophila GPR6 (Zou and Hennessey, 2017). 
Current understanding of GPR37 identifies it as a chemorepellent receptor for a currently unknown factor 
produced directly by T. thermophila cells (Zou and Hennessey, 2017). No homologues of GPRs 3, 12 and 
18 have been identified in T. thermophila to date, but they might be one of the seven remaining 
candidates that have been suggested to exist via the T. thermophila genome analysis (Lampert et al., 
2011), and which are currently being investigated.  
1.2.5.2. Peroxisome proliferator-activated receptors (PPARs)  
Peroxisome proliferator activated receptors (PPARs) are a subfamily of ligand activated receptors 
belonging to a superfamily of nuclear receptors (Tyagi et al., 2011). They are key regulators of lipid and 
glucose metabolism (Wahli et al., 1995; Varga et al., 2011). Mammalian PPARs exist in 3 isoforms: α, 
β/δ, and γ (Kliewer et al., 1994). Ligands include small lipophilic molecules such as fatty acids and their 
derivates so, due to their lipid nature, cannabinoids and their derivates exhibit PPAR α and/or γ binding 
activity; there is little evidence for the activation of PPAR β/δ (O'Sullivan and Kendall, 2010). In 
mammalian cells, AEA and 2-AG can activate both PPAR α and γ (Sun and Bennett, 2007; O'Sullivan, 
2016), OEA and PEA bind to PPAR α (Fu et al., 2003; Guzmán et al., 2004; Sun and Bennett, 2007) 
while THC and CBD (and other phytocannabinoids) bind to PPAR γ (O’Sullivan et al., 2005; O'Sullivan 
et al., 2009).  
Although no PPARs have been identified in Tetrahymena to date, they do possess peroxisomes (De Duve 
and Baudhuin, 1966; Fok and Allen, 1975) which are organelles that display PPAR mediated proliferation 
(Issemann and Green, 1990). Peroxisomes are single membrane, spherical organelles containing various 
oxidative enzymes that are mediators of oxidative reactions within eukaryotes (Smith and Aitchison, 
2013). Peroxisomes are therefore utilised in many biochemical pathways with the most notable function 
in higher eukaryotes being in β-oxidation of fatty acids (Smith and Aitchison, 2013). β-oxidation still 
appears to be the primary function of peroxisomes in Tetrahymena as the enzymatic profile suggests a 
primary role in gluconeogenesis, which requires prior oxidation of fatty acids (Takei et al., 1982).  
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Wanlahbeh (2020) showed that a range of PPAR agonists (OEA, PEA, GW0742 and Rosigitazone), 
together with CBD and AEA, induced cell death in a T. pyriformis population. The negative effect of the 
PPAR agonists was blocked with their respective isoform antagonist (OEA/PEA, PPAR α; GW0742, 
PPAR β/δ; Rosigitazone, PPAR γ). AEA-induced death was blocked by all three isoform antagonists (α, 
β/δ and γ) while CBD-induced death was only blocked by the PPAR α antagonist. Since only vertebrates 
are known to possess the three distinct PPAR isoforms (Kliewer et al., 1994), Wanlahbeh (2020) 
suggested that T. pyriformis might possess one promiscuous PPAR-like receptor that can interact with 
agonists/antagonists for the three isoforms at different sites in the molecule.  
Jaisswar (2020) investigated the effects of OEA, CBD and AEA (at 4 µM) on T. pyriformis feeding 
behaviour and found that OEA (PPAR α agonist) had no effect, while CBD and AEA immediately halted 
feeding. When feeding resumed, AEA-treated cells fed at the same rate as the Control cells whereas 
CBD-treated cells exhibited hyperphagia. Since a good proportion of T. pyriformis cells would have been 
dying at a concentration of 4 µM (Wanlahbeh, 2020), the cannabinoid-induced feeding response was 
monitored in the presence of a PPAR α antagonist. However, even though this antagonist alleviates cell 
death (Wanlahbeh, 2020) it was not able to alleviate the cessation of feeding (Jaisswar, 2020), suggesting 
that cannabinoids act on ciliate cells in at least two ways, (i) they cause cell death (which involves PPAR) 
and, 2) they affect feeding (which does not involve PPAR). This latter response differed from that of the 
amoeba Vermamoeba vermiformis which showed a similar cessation in feeding to T. pyriformis in the 
presence of CBD (but not AEA) (Al-Hammadi, 2020). In this case however, the CBD-induced feeding lag 
was blocked with the PPAR α antagonist. So, both protists respond to the PPAR α antagonist, but it stops 
cell death in T. pyriformis (with no effect on feeding) and stops the cessation of feeding in V. 
vermiformis; cell death was not monitored by Al-Hammadi (2020).  
1.2.6 Summary 
Tetrahymena clearly contains a rudimentary endocannabinoid system, equipped with a suite of 
endogenous cannabinoids including NAEs, 2-AcGs and free fatty acids. Catabolic enzymes for these 
endocannabinoids have also been identified although the anabolic enzymes have yet been elucidated. 
Furthermore, Tetrahymena can directly respond to exogenously administered cannabinoids, including the 
classical phytocannabinoids THC and CBD. Of particular interest is CBD due to its therapeutic potential.  
Previous work has identified that CBD directly affects the phagocytic feeding behaviour of Tetrahymena 
cells through a yet unidentified mechanism. However, given the wide array of potential cannabinoid 
receptors, and the paucity in the knowledge of CBD mechanisms, identifying a particular target is 
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Figure 1.4.  
Three-dimensional illustration depicting the 
basic structure of the oral cavity in the ciliate 
Tetrahymena. The cytostome-cytopharyngeal 
complex (Cy-Cyp) sits at the base of the oral 
cavity with the right wall (R) being lined by the 
oral ribs (OR) which curve down into Cy. The 
undulating membrane (UM) lines the right and 
part of the posterior margin (P) of the oral 
cavity. Several membranelles are located on 
the anterior wall (A) of the cavity. Membranelle 
1 (M1) is located next to the left wall (L) of the 
cavity, membranelle 2 (M2) sits adjacent to M1 
while membranelle 3 (M3) sits adjacent to R. 
Cilia protrude from the UM and M1,2 and 3 
but have been omitted from the illustration. 
 
(Smith 1982) 
difficult. However, in order to begin unravelling this, a good understanding of the Tetrahymena 
phagocytic mechanism is needed.  
 
1.3 The ciliate feeding mechanism 
Ciliate feeding involves several distinct steps and each is described below with special emphasis on the 
model ciliate used in the current study (Tetrahymena pyriformis) and whether evidence exists for an 
interaction with cannabinoids.  
1.3.1. Prey capture 
T. pyriformis is a classic filter feeder and as such, uses its cilia to direct prey into its oral cavity (mouth 
organelle) (Fig. 1.4). This cavity comprises 3 sections: an undulating membrane, oral ribs and 3 oral 
membranelles (M1-3) surrounding the cavity (Smith, 1982) (Fig. 1.4). The undulating membrane (UM) is 
formed from a line of kinetosomes (ciliary basal bodies) that ridge the top of the right side of the oral 
cavity and below this lie the oral ribs, a series of ridges formed from microtubules that line the right 
cavity wall (Smith, 1982) (Fig. 1.4). Opposite this, M1, 2 and 3 sit on the left wall and are covered in 3 
rows of cilia (typically longer than those found on the rest of the ciliate) (Smith, 1982) (Fig. 1.4).  
Beating of these membranelles, plus the cilia on the UM, creates currents in the extracellular fluid 
bringing prey into the cavity (Rasmussen, 1976; Smith, 1982) where they are then pushed down a ciliated 
channel (cytopharynx) and into the cytostome where they are packaged into a food vacuoles (FVs) (Elliott 














Prior to the mechanical action of packaging vacuole, ciliates must recognise their prey through a 
combination of mechanical (Fenchel, 1980; Montagnes et al., 2008) and chemosensory factors (Verity, 
1991). While ingestion of particles can seem to be unspecific because ciliates can ingest abiotic particles 
such as latex beads or indian ink (Weidenbach and Thompson, 1974; Batz and Wunderlich, 1976), 
selectivity of prey is still seen, suggesting receptor-based prey recognition is important (Ricketts, 1971; 
Montagnes et al., 2008).    
 
1.3.2 Prey recognition (Fig 1.5, Stage 1-2) 
Phagocytes utilise Pattern Recognition Receptors (PRRs) to identify structural motifs on bacterial cell 
surfaces; collectively known as Pathogen Associated Molecular Patterns (PAMPs) (Dambuza and Brown, 
2015; Rosales and Uribe-Querol, 2017). The two major classes of PRRs are C-type lectins (CLRs) and 
Scavenger receptors (SRs); both of which bind to specific carbohydrates moieties such as those found in 





















Figure 1.5. Simplified diagram representing the overall process of the ciliate phagocytic cycle. 1. Receptors available at the oral 
cavity (precise receptor location unknown) bind available prey filtered into the oral apparatus via ciliary beating. 2. Prey is swept down the 
cytopharynx into the cytostome where recycled membrane is used to form a food vacuole (FV) around the prey via the polymerisation of F-actin. 
3. Myosin activation and actin depolymerisation begins FV closure and dynactin activation facilitates scission of the FV from the cytostome. The 
Nascent FV then travels into the cytoplasm. 4. Nascent FV binds endosomes and lysosomes for FV maturation and digestion of prey 5. Mature FV 
is transported to cytoproct. 6. Indigestible particles are exocytosed via binding of FV membrane with membrane of cytoproct. 7. FV membrane is 
endocytosed from the cytoproct membrane and forms small disc-shaped vesicles. 8. Discoid vesicles are transported back to oral cytostome via a 
microtubule network and recycled for use in additional nascent FV synthesis. (Figure adapted from Al-Hammadi, 2020). 
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1.3.2.1. C-type lectin receptors (CLRs) 
CLRs encompass a superfamily of over 1000 functionally diverse proteins characterised by the possession 
of C-type lectin-like domains (CTLDs) (Dambuza and Brown, 2015; Rosales and Uribe-Querol, 2017). 
CLRs derive their name from their Ca2+ dependent binding of carbohydrates afforded by a conserved 
carbohydrate binding motif present within their CTLD (Dambuza and Brown, 2015). The two most 
prominent motifs are EPN (Glu-Pro-Asn) which binds to mannose, N-acetylglucosamine (GlcNAc), L-
fructose and glucose, and QPD (Gln-Pro-Asp) which binds to galactose and N- acetylgalactosamine 
(GalNAc) (Dambuza and Brown, 2015). Studies have revealed that protists utilise CLRs as PRRs for prey 
recognition, with CLRs that bind mannose, GalNAc and/or GlcNAc receiving the most attention. 
A receptor that binds mannose has been identified in the filter feeding ciliate Eupoltes mutabilis using 
Concanavalin A (ConA); a fluorescent lectin which binds to mannose residues (Wilks and Sleigh, 2004). 
Over a period of 10s – 30 mins, ConA bound to the cytostome first, then at the cytostome and the FVs, 
then only the FVs and then no binding was seen; labeling of the whole FV membrane was observed 
(Wilks and Sleigh, 2004). T. pyriformis also possesses such a receptor but ConA labelling only revealed 
its presence on the FVs (Dürichen et al., 2016). More recently, pre-treatment of T. pyriformis with 
100mM mannose (to block the receptor) has been shown to significantly decreases the ingestion of live 
Salmonella enterica cells by the ciliate (Boboc, 2020).   
A receptor that recognises GalNAc has been identified in Euplotes spp. using the fluorescent plant lectins 
Glycine max (soy bean) (SBA), Maclura pomifera (MPA), peanut agglutinin (PNA) and Maakia 
amurensis agglutinin (MAA), all of which bind GalNAc residues (Wilks and Sleigh, 2004). Specifically, 
lectins bound to the E. mutabilis cytostome and FVs in the first 5 minutes of feeding (Wilks and Sleigh, 
2004). More recently, pre-treatment of T. pyriformis with 100mM GalNAc (to block the receptor) has 
been shown to significantly decreases the ingestion of live Salmonella enterica cells by the ciliate (Boboc, 
2020).   
A receptor that recognises GlcNAc has been identified in Euplotes spp. using wheat germ aggultinin 
(WGA) lectins. WGA bound to the oral membranelles in Euplotes with the degree of binding being 
dependent on the species (Wilks and Sleigh, 2004). Again, in E. mutabilis lectin binding was sequential, 
as seen with ConA, and no fluorescence was observed after 60 minutes (Wilks and Sleigh, 2004). 
Conversely, WGA binding differed in T. pyriformis whereby only nascent FVs bound WGA, not older 
ones, suggesting this receptor only plays a role in the very early stages of FV formation but is excised or 
masked in the later stages (Dürichen et al., 2016). In addition, WGA binding to FVs was patchy, unlike 
30 
 
complete binding observed with ConA (Dürichen et al., 2016). More recently, pre-treatment of T. 
pyriformis with 100mM GlcNAc (to block the receptor) has been shown to significantly decreases the 
ingestion of live Salmonella enterica cells by the ciliate (Boboc, 2020).   
Receptors that recognise all three sugars (mannose, GalNac and GlcNac) have therefore been 
demonstrated to exist in T. pyriformis (Dürichen et al., 2016) but whether they are targeted by 
cannabinoids, to induce the negative effect on feeding observed by Jaisswar (2020), is currently unknown. 
Indeed, there is no evidence to date that C-type lectins can actually bind cannabinoids, although there is 
some evidence that C-type lectins can bind lipids (Cummings and McEver, 2009). Despite this, not all 
CLRs are carbohydrate-specific receptors with some lacking a carbohydrate binding domain and Ca2+ 
interaction, and instead binding proteins, lipids and even inorganic molecules (Dambuza and Brown, 
2015; Brown et al., 2018).  
The only study to date that has examined the interaction between cannabinoids and C-type lectins, and 
their effect on feeding, was carried out by Al-Hammadi (2020) on the amoeba Vermamoeba vermiformis. 
Here, the blocking of the three CLRs with 100mM of their respective sugar did not induce a feeding lag, 
whereas the presence of CBD did. Pre-blocking cells with mannose or GalNAc prior to adding CBD did 
not affect the CBD-induced lag (suggesting no interaction) but pre-blocking with GlcNAc doubled the 
length of the CBD-induced lag (suggesting an interaction) (Al-Hammadi, 2020). The exact nature of this 
interaction is currently unknown but similar experiments with T. pyriformis and CBD were carried out in 
the current study.  
1.3.2.2. Scavenger receptors (SRs) 
Scavenger receptors (SRs) are a family of receptors able to act as PRRs in macrophages (Brown and 
Goldstein, 1979). Mammalian SRs have a variety of ligands including both modified and unmodified 
endogenous lipoproteins and proteins (Canton et al., 2013) and glycans/glycosylated structures (Taylor 
and Drickamer, 2019) including some microbial structures such as lipoteichoic acid (LTA), 
lipopolysaccharides (LPS) and unmethylated bacteria DNA (Plüddemann et al., 2006; Plüddemann et al., 
2011). The grouping of SRs into classes (A-J) is based solely on their function as there is little similarity 
between the 10 classes (Zani et al., 2015). Class A and B are the most prominent SRs (Zani et al., 2015) 
with class A (SR-A) being the primary SR in macrophages and Class B primarily binding oxidised low 
density lipoproteins (OxLDL) (Zani et al., 2015). 
Despite widespread distribution in mammalian phagocytes only one paper has suggested the presence of 
SRs in protists. The slime mold Dictyostelium discoideum was shown to possess homologues of the class 
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B SRs, LIMP-2 and CD36 (Lmp A and Lmp B respectively). Lmp A was found to be associated with 
endosome transport, phagolysosome acidification/formation, and phagocytosis of mainly Gram-positive 
bacteria while LmpB was localized to the plasma membrane and early phagosomes and was exclusively 
involved in the uptake of Gram-positive bacteria (Sattler et al. 2018). To date, there are no reports of SRs 
existing in ciliates, or their involvement in phagocytosis, although a putative homologue of LmpB does 
exists in T. thermophila (Ciliate.org). The presence of SRs in T. pyriformis, and potential interaction with 
CBD, was investigated in the current study.  
1.3.3 Food vacuole formation (Fig 1.5, Stage 3)  
The exact mechanism of FV formation in Tetrahymena is not fully understood, but it is considered to be 
similar to that occurring in other phagocytes, as protists share many of the proteins known to be involved 
in phagocytosis and vacuole maturation in mammalian phagocytes (Jacobs et al., 2006). In these 
phagocytes, PRR-ligand interaction triggers intracellular signalling pathways resulting in actin 
rearrangement for pseudopodia extension and phagocytic cup formation (Rosales and Uribe-Querol, 
2017; Lee et al., 2020). Activation of actin related protein 2/3 complex (ARP2/3) via the same signaling 
pathway seeds de novo polymerisation of filamentous actin (F-actin) (Ma et al., 1998; Babuta et al., 2015; 
Lee et al., 2020). 
While filter feeding ciliates do not utilise pseudopodia, the remodeling of the actin cytoskeleton is still 
known to be involved in ciliate FV formation (Nilsson et al., 1973; Elde et al., 2005; Williams et al., 
2006). Successful FV formation in Tetrahymena requires a function ACT1 gene (actin coding gene) 
(Williams et al., 2006) and the primary actin modulating protein ADF/Cofilin (Shiozaki et al., 2013). 
Tetrahymena possesses ARP homologues including ARP 2 and 3 which are believed to also facilitate F-
actin formation (Kuribara et al., 2006), suggesting a similar ARP2/3 based mechanism to that of other 
phagocytes. However, actin is also known to play a role in FV trafficking (Méténier, 1984; Hosein et al., 
2005; Sehring et al., 2007b) and considering CBD does not affect FV trafficking in T. pyriformis 
(Jaisswar., 2020), it seems unlikely that CBD acts negatively on actin at the FV formation stage, unless 
completely different actin isoforms are employed in the two processes.  
The sealing and detachment of phagosomes is initiated by phosphoinositide signalling which triggers 
actin depolymerisation from the base of the cup (Rosales and Uribe-Querol, 2017). Signalling also 
activates myosin motor proteins to generate localised contractile forces which facilitate the closing of the 
cup (Swanson et al., 1999; Dart et al., 2012). Detachment of the phagosome membrane utilises Dynamin-
2, which carries out scission of endocytic vesicles, to excise the phagosome from the plasma membrane 
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(Marie-Anaïs et al., 2016). Dynamin is recruited to the closing phagosome via actin interactions, and 
depolymerization of actin is the trigger for dynamin activity, resulting in scission (Marie-Anaïs et al., 
2016). Tetrahymena is known to utilise dynamin for vesicle scission, with T. thermophila possessing 8 
families of dynamin related proteins (DRP 1-8) (Elde et al., 2005). There is one study that has reported 
that CBD can modulate a hippocampal dynamin‐1‐like protein (DNM1L) in the brain (Da Silva et al., 
2014) but nothing can be found on its modulation of FV closure, so FV sealing is a candidate target for 
CBD in T. pyriformis.  
In Tetrahymena, FV formation involves calcium signalling and depletion of intracellular calcium stores 
and blocking this Ca2+/CaM signalling can inhibit phagocytosis (Gonda et al., 2000; Moya and Jacobs, 
2006). In ciliates, two Ca2+/CaM interacting proteins, p85 and EF-1α, are localised to the cytostome, 
cytopharynx, and an actin based ‘deep fiber’ that connects the oral apparatus to the cytoplasm (Gonda et 
al., 2000). This deep fiber is thought to be responsible for trafficking nascent FVs from the oral apparatus 
into the cytoplasm (Gonda et al., 2000). This demonstrates Ca2+/CaM signalling involvement in both FV 
formation and trafficking, which once again makes it an unlikely target for CBD, unless CBD only 
specifically acts upon the FV formation Ca2+/CaM signal. 
1.3.4. Food vacuole maturation/digestion (Fig 1.5. Stages 4-5) 
 
FV maturation/trafficking in T. pyriformis has been shown to be unaffected by CBD treatment (Jaisswar, 
2020) but it is still worth noting the overall process for completeness. FV maturation entails fusion 
events, modification of the phagosome proteome, and a decrease in phagosome pH (Pauwels et al., 2017; 
Rosales and Uribe-Querol, 2017). Digestion can be broadly grouped into 4 stages: Stage 1. FV formation, 
Stage 2. rapid FV condensation and acidification, Stage 3. FV-lysosome fusion and digestion of FV 
contents, Stage 4. Completion of digestion and awaiting defecation (Fok et al., 1982). Maturation 
encompasses stages 2 and 3 (Fig 1.6.).  
The exact molecular mechanisms are largely unknown in ciliates, but there is a better understanding of 
the mechanisms in mammalian phagocytes. Nascent phagosomes begin by binding acidosomes which 
endower them with ATP-dependent vacuolar protein pumps (V-ATPase); used for acidification of the 
phagosome lumen (Allen et al., 1993; Yates et al., 2005). The Tetrahymena phagosome proteome 
contains 3 of these V-ATPases (Jacobs et al., 2006). Maturation then occurs via the sequential binding of 
endosomes and lysosomes which provide the necessary proteins required to generate a ‘phagolysosome’ 
(Fig 1.6.). GTPases, termed ‘Rabs’ (donated by endosomes), define the ‘early’ and ‘late’ stages of 
maturation and interact with stage-specific effectors (Meyer et al., 1998; Guerrier et al., 2017). At least 56 
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Figure 1.6. Food vacuole maturation during phagocytosis in ciliates:. A nascent phagosome is formed in the cytopharynx (CPh) using 
discoidal vesicles (DVs) recycled from the cytoproct (CPr) and recycling vacuoles (RVs) from maturing phagolysosomes (PhLy). Acidosomes/late 
endosomes (LE) fuse with nascent phagosomes and endow them with V-ATPases allowing acidification of the lumen. Fusion with lysosomes (LY) 
recycled from spent phagolysosomes, provides digestive enzymes required to form a mature phagolysosome. The nascent phagolysosome, in turn, can 
then donate recycling vesicles to nascent phagosomes at the cytopharynx. Once contents are digested a spent phagolysosome (far left phagolysosome) 
will donate lysosomes/recycling vesicles (LY/RV) to subsequent phagosomes. Any waste contents are exocytosed at the cytoproct and spent vesicle 
membrane is sent back to the cytopharynx as discoidal vesicles for nascent vacuole synthesis.  
(Figure obtained from Guerrier et al., 2017) 
Rab proteins have been identified in T. thermophila, 11 of which are associated to the FV proteome 
(Bright et al., 2010). In T. pyriformis, lysosomes donate at least 5 hydrolases for digestion: acid 
phosphatase, ribonuclease, deoxyribonuclease, amylase and protease (Rasmussen, 1976). NADPH 
oxidases also generates reactive oxidative species for additional digestive properties (Minakami and 
Sumimotoa, 2006; Nunes et al., 2013). Components of the degraded cargo are transported across the 











The time taken for the FV trafficking phase to be complete is indicated by the Vacuole Passage Time 
(VPT) (i.e. the total lifespan of one FV/phagosome). Thurman et al (2010) reported a VPT of ~30 minutes 
in T. pyriformis but also noted that this was somewhat dependent on feeding history and prey species 
(Thurman et al., 2010). Indeed, ciliates appear to possess a secondary level of prey recognition (within the 
FV) which differentiates between digestible and non-digestible particles (Ricketts, 1971; Boenigk et al., 
2001). For example, FVs of T. pyriformis which contain indigestible material do not show an increase in 
acid phosphatase activity (a biomarker for digestion) whereas vacuoles containing digestible prey do 
(Ricketts, 1971). Heterotrophic nanoflagellates also egest indigestible particles 1-2 minutes post ingestion 




1.3.5. Defecation and food vacuole membrane recycling (Fig 1.5, Stage 6-8) 
Defecation of indigestible FV cargo in ciliates occurs at a precise location called the cytoproct (Blum and 
Greenside, 1976). Egestion of also appears to occur in order, i.e., cargo of the first vacuole formed is the 
first to be defecated, and can therefore alter VPT through a backlog of vacuoles awaiting defecation 
which will affect their VPTs (Ricketts and Rappitt, 1976; Thurman et al., 2010). CBD has already been 
shown not to affect the rate of defecation in T. pyriformis (Jaisswar, 2020). 
Because there is a limited volume of membrane available in the ciliate cell for FV formation (Allen, 1974; 
Allen and Fok, 1980), old FV membrane must be recycled to the cytostome, for the formation of new 
FVs. In Paramecium and Tetrahymena it was shown that membrane from spent FVs fuses with the 
plasma membrane at the cytoproct and is then removed back into the cytoplasm, where it forms small 
disk-shaped vesicles (discoidal vesicles) (Allen and Fok, 1980). Within 3 minutes, these vesicles are 
coated with F-actin (Sugita et al., 2009) and become aligned to a bundle of microtubule ribbons, where 
they are then transported from the cytoproct to the cytostome in ca. 4 minutes (Allen and Fok, 1980). 
Considering microtubules and microfilaments in mammalian cells have been shown to be disrupted in a 
dose-dependent manner following treatment with CBD, THC and CBN (Tahir et al., 1992), this recycling 






















1.4. Conclusion and aims 
The human endocannabinoid system is responsible for mediating a broad range of neuromodulatory 
effects and has been shown to be implicated in a number of diseases and disorders. This has made the 
ECS an attractive therapeutic target through the use of cannabinoids. Of great recent interest has been the 
phytocannabinoid cannabidiol (CBD), which targets a wide variety of molecular targets beyond the 
classical ECS receptors CB1 and 2. However, details on the relative importance of each of these other 
targets on CBD functioning is patchy. The ciliate Tetrahymena is the most well studied protist with 
regards to cannabinoid interactions, and feeding, and also lacks the classical CB1/2 receptors. This makes 
it an excellent model to study the potential importance, and evolution, of these alternative CBD targets in 
eukaryotic cells.  
The aims of this study were: 
i) To determine the effect of CBD concentration on T. pyriformis feeding behaviour (ingestion rate and 
feeding lag duration).  
ii) To screen a wide variety of potential CBD receptors (based on previous literature) in an attempt to 
identify a molecular target responsible for mediating the CBD feeding effect. 
iii) Investigate the involvement of C-type lectins and scavenger receptors in T. pyriformis feeding and 



















Chapter 2. Materials and Methods 
 
2.1. Cell/microsphere maintenance and preparation 
 
2.1.1. Tetrahymena pyriformis  
The ciliate T. pyriformis (Culture Collection of Algae and Protozoa [CCAP] 1630/1W) was cultured in 
500 ml Chalkley’s medium (Appendix 1) with 3 ml of live Klebsiella aerogenes suspension (see 2.1.2). 
and incubated at room temperature (23 oC) 3 days prior to experiments.  
On the day of an experiment, the T. pyriformis culture was concentrated by centrifuging multiple tubes (of 
15 ml culture) at 2000 rpm for 20 mins at room temperature. The top 14 ml was removed, and the 
remaining 1 ml suspensions were pooled and briefly vortexed. The resulting T. pyriformis concentration, 
as determined through cell counts (see 2.2.1), varied between 5.3 x 104 - 7.5 x 105 cells/ml. 
2.1.2. Klebsiella aerogenes  
The heterotrophic bacterium K. aerogenes (National Collection of Type Cultures [NCTC] 9528) was used 
as the prey for T. pyriformis during routine culturing (see 2.1.1). The bacterium was streaked onto 
Lysogeny Broth (LB) agar plates (Appendix 1) and incubated at 25 oC for 2 days. The cells from two K. 
aerogenes plates were then suspended by pouring ca.7 ml sterile water onto each plate and dislodging the 
cells with a sterile spreader, before pooling the two suspensions. The resulting suspension was vortexed 
and stored at 4 oC.  
2.1.3. Live Synechococcus sp.  
The autotrophic bacterium Synechococcus strain S-KH3 (Dillon and Parry, 2009) was the experimental 
prey used in feeding experiments due to it being indigestible to T. pyriformis and displaying innate 
Chlorophyll a autofluorescence (red fluorescence under green excitation). The bacterium was cultured in 
Blue Green 11 (BG 11) broth (Appendix 1) at room temperature on a rotary shaker (0.00118 g) in a 16:8 
natural light:dark cycle, 5 days prior to experiments. 
On the day of an experiment, the culture was concentrated by centrifuging one tube (of 15 ml culture) at 
2000 rpm for 20 mins at room temperature. The top 13 ml was discarded, and the remaining 2 ml of 





2.1.4. Heat killed (dead) DTAF-stained Synechococcus sp.  
Live Synechococcus cells were heat-killed and stained following the method of Sherr and Sherr (1987). A 
15 ml sample of cells was heated in a 60 oC water bath for 2 hours with 5 mg of 5-(4,6-dichlorotriazinyl) 
aminofluorescein (DTAF) (Sigma). The cells were washed via centrifugation at 3500 rpm for 10 minutes, 
removing the supernatant and resuspending the pellet in 10 ml of solution 1 (Appendix 1) followed by 
vortexing and sonication for 10 minutes. This washing procedure was performed 4 times, but the final 
pellet was resuspended in 10 ml of solution 2 (Appendix 1) and left overnight at 4 oC. The suspension was 
then washed 3 more times using Chalkley’s medium.  
Cell concentration was determined (see 2.2.2) before samples were aliquoted into 300 µl samples and 
frozen at -20 oC. On the day of an experiment, an aliquot was thawed at room temperature and then 
vortexed and sonicated for 10 minutes.  
2.1.5. Fluorescently Labelled Microspheres  
Yellow/green inert fluorescently labelled microspheres (‘Beads’) (Fluoresbrite, Polyscience Inc.) of 0.49 
µm diameter were suspended in sterile water (Milli-Q) and their concentration determined (see 2.2.2) 
before storing at 4 oC. Prior to experiments, suspensions were vortexed and sonicated for 10 minutes.  
2.2. Cell/Bead counts   
2.2.1. Determining T. pyriformis concentration 
An aliquot of T. pyriformis suspension was fixed with glutaraldehyde (0.5% v/v final concentration) and 
loaded into two haemocytometers. Cells were counted in 9 medium-sized squares (x4 grids) with a light 
microscope (x40 magnification) and equation 1 was used to determine cell concentration (cells/ml). 
Equation 1: 
𝑇𝑜𝑡𝑎𝑙 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑐𝑒𝑙𝑙𝑠 𝑖𝑛 36 𝑚𝑒𝑑𝑖𝑢𝑚 𝑠𝑞𝑢𝑎𝑟𝑒𝑠 (4 𝑔𝑟𝑖𝑑𝑠)
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 × 104 = 𝐶𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛𝑠 (𝐶𝑒𝑙𝑙𝑠 𝑚𝑙)⁄  
 
2.2.2. Determining Synechococcus sp./bead concentration 
Serial dilutions of live and dead Synechococcus, or beads, were prepared down to 10-3. An aliquot was 
removed (usually 200 µl) from the 10-2 or 10-3 dilution and filtered, using a vacuum pump, onto a black 
membrane filter with a pore size of 0.2 µm (MF-Millipore, Whatman). A drop of immersion oil was 
placed onto a microscope slide onto which the membrane filter (cell/bead side up) was loaded; ensuring 
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no creases in the filter. Another drop of immersion oil was placed on top of the filter followed by a cover 
slip and another drop of oil.  
Cells/beads were viewed with an epifluorescence microscope (x1600 final magnification) using green 
excitation for live Synechococcus (cells fluoresce red) and blue excitation for dead Synechococcus and 
beads (cells/beads fluoresce yellow). The number of prey within randomly selected whipple grids 
(contained within the eyepiece) was counted until at least 400 cells/beads had been counted in total. The 
concentration (cells/ml or beads/ml) of the undiluted suspension (100) was calculated using equation 2. 
Equation 2: 
𝐴𝑣𝑒𝑟𝑎𝑔𝑒 𝑐𝑒𝑙𝑙𝑠/𝑏𝑒𝑎𝑑𝑠 𝑝𝑒𝑟 𝑊ℎ𝑖𝑝𝑝𝑙𝑒 𝐺𝑟𝑖𝑑
𝑉𝑜𝑙𝑢𝑚𝑒 𝑜𝑓 𝑠𝑢𝑠𝑝𝑒𝑛𝑠𝑖𝑜𝑛 𝑎𝑑𝑑𝑒𝑑 𝑡𝑜 𝑓𝑖𝑙𝑡𝑒𝑟 (𝑚𝑙)
 × 23068 × 𝐷𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟 (𝑖. 𝑒. 103) 
                                                                   = 𝐶𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 (𝑃𝑟𝑒𝑦 𝑚𝑙)⁄   
2.2.3. Counting prey inside T. pyriformis cells 
Feeding experiments generated fixed samples of T. pyriformis from which 8µl was placed onto a 
microscope slide and covered with a coverslip, then a drop of immersion oil. Cells were viewed with an 
epifluorescence microscope (x1600 final magnification) using bright light (to locate ciliate cells) and then 
either green or blue excitation (to view the prey inside). The number of prey/cell (P/C) and food 
vacuoles/cell (V/C) for 10 ciliate cells were determined per sample, for triplicate samples, and the average 
taken.  
2.3. Experimental compounds 
2.3.1. Cannabidiol (CBD) 
A 10 mM stock solution of Cannabidiol (CBD) (TOCRIS) was prepared in ethanol and stored at -20 oC. 
On the day of an experiment, 10-1 and/or 10-2 dilutions were prepared in Chalkley’s medium depending on 
experimental requirements, e.g., for 4 µM CBD, 4 µl of 10-1 CBD dilution was added to 1 ml T. 
pyriformis suspension for 5 minutes, prior to addition of any prey. 
2.3.2. C-type lectin receptor (CLR) and scavenger receptor (SR) blockers 
One mol/L stocks of D (+)-Mannose (M6020), N-Acetyl-α-D-glucosamine (GlcNAc) (A3286) and N-
Acetyl-D-galactosamine (GalNAc) (A2795) (Sigma), and 400 mg/ml stocks of Dextran Sulphate (DS) 
(D8906) and Chondroitin Sulfate A bovine (CS) (C9819) (Sigma), were prepared in water on the day of 
an experiment. Incubation of T. pyriformis for 30 min with Mannose, GlcNAc and GalNAc (at 100 mM) 
blocks their respective C-type lectin receptor (CLR) whilst a 30 min incubation with DS (at 400 µg/ml) 
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blocks scavenger receptors A and B (SRs) - CS is structurally related to DS but does not bind SRs and is 
used as an additional control.     
2.3.3. Other antagonists/receptor blockers 
A number of antagonists (Table 2.1) were used to block presumptive CBD-interacting receptors in T. 
pyriformis (Table 1.1.), and components of the MAPK pathway, prior to the addition of CBD. The 
working concentration of all blockers was 10 µM except for PTX and Melittin which were 100 ng/ml and 
0.3 µM respectively (Appendix 2). The ciliate was pre-incubated with the blocker for 30 mins (PTX, 5 
hours) prior to the addition of CBD.   
Table 2.1. Summary of receptor antagonists (TOCRIS), their solvent and molecular target. All stocks were prepared 
at 10 mM and stored at -20 oC apart from PTX (0.1 µg/µL, 4 oC) and Melittin (0.3 mM, 4 oC). 
Antagonist (TOCRIS Cat No.) Solvent  Molecular target  
PPARs 
GW9662 (1508) Ethanol General PPAR antagonist for all isoforms 
TRPV 
Capsazepine (0464) Ethanol General Vanilloid receptor antagonist  
GPCRs 
Gallein (3090) DMSO All GPCRs - βγ complex inhibitor  
Pertussis Toxin (PTX) (3097) Distilled Water 
Gi/o and Gt inhibitor (includes CB1, CB2, Dopamine 
D2, Adenosine A1, Serotonin 5-HT1A and Opioid [all 
forms]) 
Melittin (1193) Distilled Water 
Gs inhibitor (includes GPR55, GPR119 and the two 
GPRs in T. pyriformis [6 and 37])   
Dopamine D1  
LE300 (1674) DMSO 
Selective D1 receptor antagonist (D2 blocked by 
PTX) 
 
Serotonin 5-HT2A  
EMD281014 (4470) Ethanol 
Selective 5-HT2A antagonist (5-HT1A blocked by 
PTX) 
 
Adenosine A2  
ZM241385 (1036) DMSO Selective A2 antagonist (A1 blocked by PTX)  
Components of MAPK pathway  
PD98059 (1213) DMSO MEK inhibitor    
U0126 (1144) DMSO Selective MEK1/2 inhibitor  
SB 203580 (1202) DMSO P38 MAPK inhibitor  






2.4. Effect of CBD concentration on T. pyriformis feeding  
These experiments were not all performed at the same time, due to the numerous CBD concentrations 
being tested (0 µM, 0.5 µM, 1 µM, 1.5 µM, 1.75 µM, 2 µM, 2.25 µM, 2.5 µM, 2.75 µM, 3 µM, 3.25 µM, 
3.5 µM, 4 µM, 4.5 µM and 6 µM). Experiments were performed at room temperature and there now 
follows an example of how each CBD concentration was tested. 
Concentrated ciliate and prey suspensions were prepared (see 2.1.1., 2.1.3.– 2.1.5.) and concentrations 
determined (see 2.2.1. and 2.2.2.). Six 500 µl T. pyriformis aliquots were prepared and the desired volume 
and dilution of CBD (see 2.3.1) was added to three tubes (Tests) for 5 minutes (Control tubes received an 
equivalent volume of Chalkley’s medium). Then, live Synechococcus was added to all 6 tubes to give a 
starting concentration of 1 x 107 cells/ml (this was time zero). Aliquots (50 µl) were removed from the 
tubes every 5 min, over a 120 min period, and fixed with glutaraldehyde (0.5% v/v final conc.). For each 
of the 3 replicas, P/C was determined for 10 cells (see 2.2.3).  
Each concentration was tested twice (n = 6) and each replica generated a graph of P/C verses time, from 
which linear regression analysis allowed the identification of, (i) ingestion rate (IR)(prey/cell/min), from 
the gradient of the fitted line and, (ii) feeding lag time (min), from where the fitted line crossed the X-
axis, where P/C = 0.  The average ± SEM of IR and feeding lag was then determined.  
2.5. Effect of blocking T. pyriformis receptors on its feeding behaviour 
2.5.1. Preliminary toxicity experiments  
The working concentrations of the blockers were determined from the literature and are summarised in 
Appendix 2. However, prior to carrying out blocking experiments, the proposed working concentration 
was tested against a suspension of T. pyriformis for 120 min (30 min for sugars) to confirm no negative 
effect on cell concentration. Controls received an equivalent volume of solvent. Experiments were 
repeated twice (n = 6). 
2.5.2. Blocking receptors (other than CLRs and SRs) 
Concentrated ciliate and prey suspensions were prepared (see 2.1.1., 2.1.3.– 2.1.5.) and concentrations 
determined (see 2.2.1. and 2.2.2.). Half of the T. pyriformis suspension was pre-incubated, at room 
temperature, with the receptor blocker (‘Blocked’) at its working concentration for the required duration 
(see 2.3.3). The other half (Control) received the same volume of solvent. Each was then divided into 6 
aliquots and CBD was added to three (at 4 µM, ‘+CBD’) while the remaining three received an equivalent 
volume of ethanol (‘-CBD’). This yielded four experimental systems (each in triplicate): Control (no 
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blocker and no CBD), CBD alone, blocker alone and CBD with blocker. After 5 min, live Synechococcus 
was added to all 6 tubes to give a starting concentration of 2 x 107 cells/ml. The ciliate was left to feed on 
the prey for 20 minutes before being fixed with glutaraldehyde (0.5% v/v final conc.). For each of the 3 
replicas, P/C and V/C was determined for 10 cells (see 2.2.3). This experiment was repeated three times 
(n = 9) and each replica generated a value for P/C and V/C after 20 mins feeding. The average ± SEM 
was then determined.  
2.5.3 Blocking C-type lectin receptors (CLR) and Scavenger Receptors (SRs) 
2.5.3.1 Experiments devoid of CBD – CLRs and SRs 
For CLR blocking, a T. pyriformis suspension was divided into four aliquots and pre-incubated at room 
temperature, for 30 min, with either mannose, GlcNac, GalNac (at 100 mM, ‘Blocked’), or left untreated 
(Control). Each of these four systems was then divided into 9 aliquots and prey was added at a 
concentration of 2 x 107 cells/ml. For each ‘Blocked’ and ‘Control’ system, live Synechococcus was 
added to three tubes, dead Synechococcus was added to three tubes and finally, beads were added to three 
tubes. The ciliate was left to feed on the prey for 5 min before being fixed with glutaraldehyde (0.5% v/v 
final conc.). For each of the 3 replicas, P/C and V/C was determined for 10 cells (see 2.2.3). This 
experiment was repeated three times (n = 9) and each replica generated a value for P/C and V/C after 5 
mins feeding. The average ± SEM was then determined.  
The experiment for SR blocking followed that described above but the ciliate was pre-incubated with DS, 
CS (both at 400 µg/ml, ‘Blocked’) or left untreated (Control).  
2.5.3.2. Experiments involving CBD – CLRs only  
A T. pyriformis suspension was divided into four aliquots and pre-incubated at room temperature, for 30 
min, with either mannose, GlcNac, GalNac (at 100 mM, ‘Blocked’), or left untreated (Control). Each of 
these four systems was then divided into 18 aliquots and CBD was added to nine (at 4 µM, ‘+CBD’) 
while the remaining nine received the same volume of ethanol (‘-CBD’). After 5 min, prey was added at a 
concentration of 2 x 107 cells/ml. For each ‘Blocked’ and ‘Control’ system, live Synechococcus was 
added to three ‘+CBD’ tubes and three ‘-CBD’ tubes, dead Synechococcus was added to three ‘+CBD’ 
tubes and three ‘-CBD’ tubes and finally, beads were added to three ‘+CBD’ tubes and three ‘-CBD’ 
tubes (this was time zero). Aliquots (50 µl) were removed from the tubes every 5 min, over a 120 min 
period, and fixed with glutaraldehyde (0.5% v/v final conc.). For each of the 3 replicas, P/C was 
determined for 10 cells (see 2.2.3). This experiment was repeated twice (n = 6) and each replica generated 
a value for lag and IR from which the average ± SEM was determined. 
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2.6. Statistical analysis 
Data comprising two variables (3.3 – 3.5, 3.6.2) were subject to an independent student T-test with a 
confidence limit of 95% (P≤0.05). Data comprising >2 variables (3.1, 3.2, 3.6.1) were subject to a one-




















Chapter 3. Results 
3.1. The effect of CBD concentration on T. pyriformis feeding 
T. pyriformis was subjected to a range of CBD concentrations and the feeding lag period (min) and 
ingestion rate (prey/cell/min), with Live Synechococcus, were determined at each concentration (Fig. 3.1).  
 
Figure 3.1. The effect of CBD concentration (µM) on the feeding lag (min) and ingestion rate (IR, prey/cell/min) of 
T. pyriformis, feeding on live Synechococcus at 1 x 107 cells/ml. Continuous green line denoted IR before the onset 
of a lag, while dotted green line denotes IR after the feeding lag. Data points are an average 6 replicas (± SEM). 
 
CBD concentrations of 0.25-1.75 µM had no significant effect on T. pyriformis feeding, i.e., no feeding 
lag was induced and instantaneous IR was equivalent to the Control (P>0.01) (Fig. 3.1., continuous green 
line). At 2 µM, IR significantly reduced (P<0.01) until it was zero at 2.5 µM; suggesting an MIC of 
>1.75≤2 µM (Fig. 3.1, continuous green line). This cessation of feeding at 2.5 µM led to a feeding lag of 
5 min (Fig. 3.1., blue line) and when feeding resumed, IR was 1.4 prey/cell/min (Fig. 3.1. dotted green 
line). This IR was not significantly different to the Control, as was the IRs up to 3.25 µM (P>0.01), but 
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the Control (P<0.01) (‘hyperphagia’) and continued to increase, with increasing CBD concentration, 
alongside a less rapid rise in lag phase (Fig. 3.1).  
There was a significant correlation (R2 0.888) between lag period duration and subsequent IR (Fig. 3.2). 
This suggests that the primary target of CBD is to stop feeding completely and induce a lag (which is 
dose-dependent), and then, possibly after the CBD wears off or is degraded, the subsequent IR is directly 
proportional to the length of that lag. So, it appears that a lag period of ca. 32 mins is required to induce 









Figure 3.2. Relationship between the length of the CBD-induced lag period (min) and the subsequent ingestion rate 
(prey/cell/min). Equation of the line is displayed on the graph and data were acquired from Figure 3.1. 
 
3.2. Toxic effects of antagonists/blockers on T. pyriformis  
Working antagonist concentrations were screened for cytotoxic effects prior to using in feeding 
experiments. All sugars (at 100 mM, Fig 3.3A), PTX (at 100 ng/ml) and all other receptor antagonists 
except Melittin (at 10 µM, Fig 3.3B) proved to be non-toxic to the ciliate – as determined by no 
significant change in cell concentration over 120 min in their presence (P>0.05) (Fig. 3.3). All antagonists 
against components of the MAPK pathway (at 10 µM, Fig 3.3C) also proved non-toxic.  
Due to the detected melittin toxicity, additional melittin concentrations were tested and a working 
concentration of 0.3 µM was accepted as being non-toxic to the ciliate (P>0.05) (Fig. 3.4). This was used 
as the new working concentration.  
 
 





















































Figure 3.3. Concentration of T. pyriformis cells (cells/ml) after incubation with A) 100 mM Mannose, N-Acetyl-α-
D-glucosamine (GlcNAc), N-Acetyl-D-galactosamine (GalNAc) and 400 µg/ml of Dextran Sulphate (DS) and 
Chondroitin Sulphate (CS) for 30 min. B) 10 µM of EMD281014, Capsazepine, ZM241385, GW9662, LE300, 
Melittin, and Gallein, and 100ng/ml of PTX for 120 min. C) 10 µM of U0126, PD98059, SB203580, ZM336273 for 






























































Figure 3.4. Concentration of T. pyriformis cells (cells/ml) after a 120-min incubation with varying Melittin 
concentrations. Data are averages (± SEM) of 3 experiments (n = 9).  * = significantly different to control 
(P<0.01). 
 
3.3. The effect of blocking receptors and components of the MAPK pathway  
Tables 3.1-3.3 show that the presence of CBD significantly reduced P/C compared to the Control 
(P<0.01), but none of the antagonists tested alleviated this negative response. In addition, none of the 
antagonists affected the P/C in the absence of CBD (Tables 3.1-3.3), suggesting that none are even 
involved in the normal feeding behaviour of T. pyriformis. 
Table 3.1. Number of prey/cell in T. pyriformis cells feeding on live Synechococcus after pre-incubation with GPCR 
antagonists Gallein (βγ complex), PTX (Gi/o and Gt), and Melittin (Gs) followed by CBD addition. Results are 
averages (± SEM) of 2 experiments (n = 6). * = significant difference between with and without CBD (P<0.01). 
Antagonist Prey/cell 
 Without CBD (± SEM) With CBD (± SEM) 
Control 24.70 (±1.45) 0.67 (±0.19)* 
+ Gallein 23.18 (±1.11) 0.73 (±0.17)* 
+ Pertussis Toxin (PTX) 25.08 (±1.37) 1.23 (±0.33)* 
























Table 3.2. Number of prey/cell in T. pyriformis cells feeding on live Synechococcus after preincubation with non-
GPCR antagonists Capsazepine (TRVP), EMD281014 (5-HT2A), GW9662 (all PPARs), ZM241385 (Adenosine A2), 
LE300 (Dopamine D1), followed by CBD addition. Results are averages (± SEM) of 2 experiments (n = 6). * = 
significant difference between with and without CBD (P<0.01). 
Antagonist Prey/cell 
 Without CBD (± SEM) With CBD (± SEM) 
Control  26.68 (±1.41) 0.45 (± 0.12)* 
+ Capsazepine 24.43 (±1.63) 0.53 (±0.18)* 
+ EMD281014 25.77 (±1.69) 0.17 (±0.10)* 
+ GW9662 25.40 (±2.12) 1.17 (±0.36)* 
+ ZM241385 26.18 (±1.83) 0.25 (±0.10)* 
+ LE300 26.35 (± 1.78) 1.14 (±0.36)* 
 
Table 3.3. Number of prey/cell in T. pyriformis cells feeding on live Synechococcus after preincubation with MAPK 
pathway component antagonists U0126 (MEK1/2), PD98059 (MEK), SB203580 (P38 MAPK), and ZM336372 (c-
Raf), followed by CBD addition. Results are averages (± SEM) of 2 experiments (n = 6). * = significant difference 
between with and without CBD (P<0.01). 
Antagonist Prey/cell 
 Without CBD (± SEM) With CBD (± SEM) 
Control 21.19 (±1.25) 0.28 (±0.14)* 
+ U0126 23.63 (±1.65) 0.23 (±0.11)* 
+ PD98059 24.50 (±1.67) 0.12 (±0.08)* 
+ SB203580 23.45 (±1.66) 0.32 (±0.16)* 
+ ZM336372 23.00 (±1.93) 0.28 (±0.15)* 
 
3.4. The effect of blocking C-type lectin receptors (CLRs) and scavenger receptors (SRs)  
3.4.1. Effect on T. pyriformis feeding in the absence of CBD 
T. pyriformis cells were subject to a 30-minute pre-incubation period with one of 5 sugars (Mannose, 
GlcNac, GalNac, DS or CS) in order to block their corresponding receptor. Cells were then fed with 3 
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types of prey: live Synechococcus, dead Synechococcus and inert beads, for 5 minutes, before fixing in 
glutaraldehyde (0.5% v/v final conc). Average Prey/cell (P/C) and Vacuoles/cell (V/C) were recorded. 
3.4.1.1 Effect of prey type  
Comparison of the uptake of the three prey types after 5 min in the Control T. pyriformis cells only (Fig. 
3.5), shows a striking pattern, in that live Synechococcus cells are ingested significantly more than dead 
Synechococcus cells or beads (P<0.01), which were themselves equivalent (P = 0.9) (Fig. 3.5, A, C, E, 
Fig. 3.6 A). Live Synechococcus cells also induced in the formation of significantly more food vacuoles 
than dead Synechococcus cells and beads (P<0.01), which were themselves equivalent (P=0.75) (Fig. 3.5, 
B, D, F, Fig. 3.6 B).  
3.4.1.2. Blocking CLRS  
The pre-blocking of CLRs (with Mannose, GalNAc or GlcNAc), prior to adding prey, also showed a 
striking pattern (Fig. 3.5.). Firstly, no matter what receptor was blocked, the uptake of, and food vacuole 
formation in the presence of, beads was not significantly affected (P/C: P=0.116, V/C: P=0.157). At the 
other extreme, the uptake of prey (P/C) and vacuole formation (V/C) with live Synechococcus cells was 
significantly reduced in the presence of all three sugars.  Blocking with mannose decreased uptake of live 
cells by 36.9% (P<0.01), compared to the un-blocked Control, and the formation of food vacuoles was 
reduced by 27% (P<0.01). Blocking with GlcNAc reduced prey uptake and food vacuole formation by 
40.52% and 33.7%, respectively (P<0.01) while blocking with GalNAc reduced prey uptake and food 
vacuole formation by 47.9% and 40.48% (P<0.01), respectively. 
The effect of receptor blocking on dead Synechococcus cells differed in that, blocking CLRs with 
mannose or GlcNAc caused no significant reduction in P/C or V/C (Mannose P/C: P=0.65, V/C: P=0.089; 
GlcNAc P/C: P= 0.18, V/C: P= 0.11) (Fig 3.5, A-D). However, blocking with GalNAc did reduced dead 
prey uptake by 32% (P<0.01) and lowered food vacuole formation by 25% (P<0.01) (Fig 3.5, E, F). 
These data suggest that the uptake of live Synechococcus cells involves all three CLRs, the uptake of dead 































Figure 3.5. Number of Prey/cell and Vacuoles/cell in T. pyriformis cells after pre-incubation with A, B: D (+) 
Mannose; C, D: N-Acetyl-α-D-glucosamine (GlcNAc); E, F: N-Acetyl-D-galactosamine (GalNAc) at 100 mM for 30 
min, and then feeding with Synechococcus sp. (live or dead) or beads (at 2 x 107 particles/ml) for 5 minutes. Data 
are averages (± SEM) of 3 experiments (n = 9) * = significantly different to Control (P<0.01).  
 
3.4.1.3. Blocking SRs  
Pre-incubating T. pyriformis with dextran sulphate (DS) (and chondroitin sulphate [CS] as an additional 





















































































































Synechococcus and beads (Dead: P/C P=0.90, V/C P=0.71; Beads: P/C P=0.90, V/C P=0.90) (Fig 3.6.). It 
also did not affect vacuole formation in the presence of live Synechococcus cells (P = 0.76) (Fig 3.6. B), 
however, P/C with these live cells significantly reduced by 12.9% (P<0.01) (Figure 3.6. A). This suggests 









Figure 3.6. Number of Prey/cell (A) and Vacuoles/cell (B) in T. pyriformis cells after pre-incubation with Dextran 
sulphate (DS) and Chondroitin Sulphate (CS) at 400 µg/ml for 30 min, and then feeding with Synechococcus sp. 
(live or dead) or beads (at 2 x 107 particles/ml) for 5 minutes. Data are averages (± SEM) of 3 experiments (n = 9) * 
= significantly different to Control (P<0.01).  
  
3.4.2. Effect on T. pyriformis feeding in the presence of CBD 
Following clear evidence for the involvement of Mannose, GalNAc, and GlucNAc CLRs in the uptake of 
live Synechococcus cells by T. pyriformis, feeding experiments were performed to test whether CLRs 
interacted with CBD. CLRs were pre-blocked with the sugar and ciliate feeding was monitored in the 
presence/absence of a subsequent dose of CBD (4 µM).  
Figure 3.7 shows the feeding response of T. pyriformis over time and clearly shows a reduced IR in the 
presence of sugar blocking (as seen in the 5 min experiments in 3.4.1) however, these data do now 
confirm that it is not due to presence of a lag period but it a true reduction in IR. This reduction was 
significant in all cases (P<0.01) with Mannose, GalNAc and GlcNAc reducing IR by 59.4%, 43.1%, and 
54.5% respectively (Table 3.4).  
In the absence of a sugar (Control), with CBD, a significant feeding lag, followed by hyperphagia was 
recorded (Fig. 3.7, Table 3.4). In these experiments, the lag period averaged 59.35 min (Table 3.4), which 



























































Figure 3.7. Feeding of T. pyriformis cells on live Synechococcus after pre-incubation with Mannose (A), GalNAc 
(B) or GlcNAc (C) at 100mM. Feeding was then performed in the absence/presence of 4µM CBD. Data are 

































































Table 3.4. Feeding lag (mins) and subsequent ingestion rate (IR) in T. pyriformis cells feeding on live 
Synechococcus at 1 x 107 cells/ml. Cells were preincubated, for 30 minutes with one of three sugars: Mannose, 
GalNAc or GlcNAc (at 100 mM) and feeding in the presence/absence of 4 µM of CBD was recorded. Data are 
averages (± SEM) of 2 experiments (n=6). Significant difference (P<0.01) to: ^ = Respective sugar with no CBD,  
“ = Control with no CBD and no sugar, * = Control with CBD. 
Sugar Condition Without CBD  With CBD 
Control 
Feeding Lag (min) 0 59.35 (± 0.320) “ 
Ingestion Rate (prey/cell/min) 1.43 (± 0.065)  2.09 (± 0.074) “ 
Mannose 
Feeding Lag (min) 0 54.41 (± 3.40) ^ “ 
Ingestion Rate (prey/cell/min) 0.85 (± 0.079) “ 1.31 (± 0.087) ^ * 
GalNAc 
Feeding Lag (min) 0 57.70 (± 1.57) ^ “ 
Ingestion Rate (prey/cell/min) 0.62 (± 0.063) “  1.13 (± 0.071) ^ “ *    
GlcNAc 
Feeding Lag (min) 0 58.38 (± 1.40) ^ “ 
Ingestion Rate (prey/cell/min) 0.78 (± 0.058) “ 1.31 (± 0.057) ^ * 
 
Pre-incubating cells with sugars, prior to the addition of CBD, did not affect the duration of the CBD-
induced lag (Fig. 3.7, Table 3.4), even though Mannose does appear to allow a slight earlier onset of 
feeding compared to GalNAc and GlcNAc (Fig. 3.7 A). However, all sugars significantly reduced (but 
did not abolish) the extent of the CBD-induced hyperphagia (Mannose and GlcNAc by 37% and GalNAc 













Chapter 4. Discussion  
 
4.1. Summary of results 
The main aim of this study was to investigate the potential molecular targets that are responsible for 
mediating CBD-induced changes in the feeding behaviour of T. pyriformis. These changes were first 
evaluated at different concentrations of CBD and it appeared that the primary response of the ciliate to 
CBD was a reduction in ingestion rate (IR) (at >1.75≤2 µM CBD). IR was then zero (at ≥2.5 µM CBD) 
and this gave rise to a feeding lag. The lag was however temporary, with its duration being positively 
correlated to CBD concentration. Following the lag’s cessation, the ciliate began to feed again and the 
resulting IR correlated positively with the duration of the lag. A lag duration of 32 min led to IRs that 
were significantly higher than those in the untreated controls; the ciliate exhibited hyperphagia.  
In light of a dose-response effect a dozen putative CBD molecular targets were screened for any potential 
involvement in the mediation of CBD-induced feeding changes. These targets were either known 
cannabinoid interacting-receptors or were common MAPKs which are widely known to be involved in 
eukaryotic cellular reception of external stimuli. Unfortunately, none of the tested antagonists were able 
to alleviate the CBD-induced lag phase, nor did they affect feeding behaviour in non-treated cells which 
suggests that these targets are not involved in normal T. pyriformis feeding either.  
As an extension of the prior experiments, this study also investigated the involvement of CLRs and SRs 
in normal T. pyriformis feeding via receptor blockage with their respective sugars (mannose, GalNAc and 
GlcNAc). Feeding on 3 prey types was monitored: (i) live Synechococcus (ii) heat-killed (dead) 
Synechococcus and, (iii) inert latex beads. None of the CLRs or SRs were involved in the processing of 
the beads. All 3 CLRs were implicated in the uptake of, and vacuole formation with, live Synechococcus 
whereas SRs were only implicated in the ingestion of live Synechococcus (but not vacuole formation in its 
presence). Only GalNAc was implicated in the uptake of, and vacuole formation with, dead 
Synechococcus suggesting the heat treatment had destroyed the Mannose and GlcNAc receptor ligands on 
the live Synechococcus cells. 
CLRs were also tested as candidates for CBD affect mediators. CLR blockage, with their respective 
sugar, was not able to alleviate the CBD-induced lag phase. However, all 3 sugars reduced the subsequent 





4.2. T. pyriformis feeding in the absence of CBD 
4.2.1 Receptors involved in the uptake of live, dead and inert prey by T. pyriformis 
The feeding of T. pyriformis on three prey types was investigated; live Synechococcus, heat-killed-DTAF-
stained Synechococcus (Dead) and fluorescent microspheres (beads). A striking pattern was recorded, in 
that, live Synechococcus cells were ingested significantly more than dead Synechococcus or beads, which 
were themselves equivalent. Live Synechococcus also resulted in the formation of significantly more food 
vacuoles than dead Synechococcus and beads, which were themselves equivalent.  
Pre-blocking T. pyriformis cells with mannose, GalNAc, GlcNAc or dextran sulphate showed that 
ingestion/food vacuole formation with live Synechococcus involved all three C-type lectin receptors 
(CLRs) and, for ingestion only, Scavenger Receptors (SRs). The involvement of all three CLRs has 
previously been reported for live Synechococcus ingestion by the amoeba V. vermiformis (Al-hammadi, 
2020) and for live Salmonella enterica ingestion by T. pyriformis (Boboc, 2020). Potential SR 
involvement has also very recently been observed in the ingestion of live Synechococcus by T. pyriformis 
(Parsons, 2021).  
The ingestion/food vacuole formation with beads did not involve any of these receptors, as has been 
reported previously, albeit only for the mannose receptor (Allen and Dawidowicz, 1990; Boboc, 2020) 
and SRs (Parsons, 2021). Only the GalNAc receptor was involved with ingestion/food vacuole formation 
with dead Synechococcus suggesting that the mannose and GlcNAc receptors are more heat labile than 
the GalNAc receptor. Considering that ingestion/food vacuole formation with beads (no receptors) and 
dead Synechococcus (GalNAc receptor) were equivalent, it either suggests that GalNAc is less important 
than mannose/GlcNAc receptors in T. pyriformis feeding (but this was not evident with live cells, where 
the blocking GalNAc produced the greatest reductions in P/C and V/C of all 3 CLRs) or, that beads enter 
the cell via a different route to bacterial prey and their ingestion cannot be directly compared to that of 
dead cells.  
Vogel et al. (1980) was the first to postulate that different prey types enter a protist cell via two 
functionally distinct routes: a non-specific receptor-based route (primary governed by hydrophobicity), 
and a receptor route (based on the recognition of prey by a lectin receptor). Since inert particles have no 
surface ligands which are recognizable by CLRs or SRs, they are thought to enter via the first route. It has 
also been postulated that this unselective phagocytosis of inert particles is attributed to a ‘mechanical’ 
action only, where particle ingestion and vacuole formation is induced by the physical action of a particle 
entering the cytostome; and circumventing the need for any receptor-ligand interactions (Allen and Fokt, 
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2000; Grønlien et al., 2002). This would give rise to a basal (low) ingestion/vacuole formation rate which, 
based on the current study, would be 9 beads/cell in 5 min and 1.8 vacuoles/cell in 5 min (at 2 x 107 
beads/ml). In contrast, live prey uptake is attributed to a combination of mechanical and biochemical 
mechanisms (Montagnes et al., 2008), creating a cumulative ingestion/vacuole formation rate, hence the 
consistently greater ingestion of live cells over beads as seen in this and other studies (Elliott and 
Clemmons, 1966; Sherr and Sherr, 1987; Nygaard et al., 1988; Boenigk et al., 2001a; Parry et al., 2001; 
Grønlien et al., 2002; Boenigk and Novarino, 2004). 
4.2.2. Interaction between Synechococcus and the receptors  
4.2.2.1. Mannose and the mannose receptor 
Polysaccharides are common in bacterial cells and mannose residues can be found in a range bacterial 
structures such as the core oligosaccharides and O-antigens of the LPS layer, or in the glycoproteins 
comprising the S layer (Sahly et al., 2002; Golowczyc et al., 2009; Man-Kupisinska et al., 2018). 
However, the composition of the Synechococcus LPS layer appears to have a low proportion of mannose 
residues compared to other oligosaccharides (Snyder et al., 2009). Even so, mannose has been found in 
the O-antigens of S. elongatus suggesting a wider distribution of this sugar (Katz et al., 1977; Fujii et al., 
2012). Synechococcus cells do possess an S-layer which is comprised mainly of the glycoprotein SwmA 
(McCarren and Brahamsha, 2009; Strom et al., 2017). However, it seems to possess little to no mannose 
residues, as it exhibits no interaction with the mannose binding lectin Concanavalin A (Con A) (Strom et 
al., 2017). This might explain why pre-blocking T. pyriformis with mannose in the current study resulted 
in the smallest (though still significant) reduction in P/C and V/C, compared to blocking with GlcNAc 
and GalNAc.  
It was noticeable that upon heat-treatment of Synechococcus, the mannose receptor was unable to interact 
with these dead cells, suggesting that the mannose residues were heat-labile. This contrasts with the cells 
of Salmonella enterica, where the mannose receptor is involved in the uptake up, and food vacuole 
formation with, dead cells, suggesting this species possessed more heat-stable mannose residues (Boboc, 
2020). Synechococcus on the whole does seem to be very sensitive to heat treatment. Boboc (2020) 
showed that heat-killing Synechococcus resulted in an ingestion rate similar to that seen by beads. This 
was an identical response to that observed in the current study, and is presumably solely due to the 




4.2.2.2 GalNac and the GalNAc receptor  
The pre-blocking of T. pyriformis with GalNAc resulted in the most significant reduction in P/C and V/C 
with live Synechococcus, suggesting that GalNAc residues are abundant in/on its cells. However, GalNAc 
residues are not considered to comprise a significant part of the LPS of Synechococcus (Snyder et al., 
2009) and no further information about its presence in other cell structures could be found by the author. 
In other bacteria, GalNAc is present in many structures, including lipooligosaccharide, capsules, cell wall 
teichoic acids and O-antigens (Michael et al., 2002; Freymond et al., 2006; Liu et al., 2014a).   
Protistan GalNAc receptors are known to bind galactose in addition to GalNAc (Venkataraman et al., 
1997; Padilla-Vaca et al., 1999) and galactose is a significant component in the LPS layers of several 
species of Synechococcus (Snyder et al., 2009). Therefore, the blocking of the GalNAc receptor by 
GalNAc might have been preventing an interaction between the receptor and galactose (not GalNAc) 
moieties in/on Synechococcus cells.   
The GalNac receptor was the only receptor involved in the ingestion of heat-killed Synechococcus 
showing that the ligands are somewhat heat-stable. The decrease in prey uptake and vacuole formation 
caused by GalNAc blockage when fed with dead Synechococcus (32% and 25%, respectively) was 
smaller than the decrease seen when fed with live Synechococcus (48% and 41%, respectively) which 
suggests a partial loss of residues. In mammalian cells, receptors for GlcNAc and mannose possess the 
same tripeptide carbohydrate recognition domain (EPN motif) whereas receptors for GalNAc possess a 
QPD motif (Dambuza and Brown, 2015; Brown et al., 2018). If this pattern is conserved in protists, it 
seems likely that ligand that bind to the EPN motif are lost/more severely damaged during heat treatment, 
whereas the QPD ligand is at least partially retained. GalNAc ligands seem to be more conserved across 
species as S. enterica also seemed to possess a partially heat-stable GalNAc ligand which was utilised in 
its uptake by T. pyriformis.  
4.2.2.3. GlcNAc and the GlcNAc receptor  
GlcNAc residues are found at a relatively low proportion in the LPS of Synechococcus, even when 
compared to mannose (Snyder et al., 2009). However, this is likely because GlcNAc is typically localised 
to the peptidoglycan (within the cell wall) where it forms one of the two primary components (repeating 
units of GlcNAc and N-acetylmuramic acid [MurNAc)]) (Dörr et al., 2019). Knowing that cyanobacteria 
possess a cell wall that is significantly thicker than normally seen in Gram-negative bacteria (~10 nm in 
most Synechococcus) (Hoiczyk and Hansel, 2000) it is now clear as to why blocking GlcNAc receptors 
had such a significant effect on live Synechococcus uptake; this thicker cell wall would be a major ligand 
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for the T. pyriformis GlcNAc receptor. Little information could be found on other cellular locations of 
GlcNAc in Synechococcus but beyond Synechococcus, several other bacterial species interact with the 
PRR Dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin (DC-SIGN) through 
GlcNAc interactions (Maeda et al., 2003; Klena et al., 2005; Zhang et al., 2006).  
As with mannose, GlcNAc receptors played no role in the uptake of dead cells, suggesting complete loss 
of GlcNAc residues in/on the Synechococcus cells. Peptidoglycan is not heat liable at 40-50oC (but is at 
>50oC) although true gram-positive cell walls (i.e. ~40nm seen in gram positive species (Hoiczyk and 
Hansel, 2000)) are more resilient than thinner gram-negative walls (Russell, 2003). It is likely that the 
60oC temperature used in the heat treatment here was sufficient to completely destroy the 10nm layer 
peptidoglycan in Synechococcus. As previously stated, mannose and GlcNAc residues share an EPN 
carbohydrate recognition motif, and so can often share ligands (Zhang et al., 2006; Dambuza and Brown, 
2015). It is likely that there was overlap in the ligands used to bind to the mannose- and GlcNAc receptors 
of T. pyriformis which could explain why blockage of either of them had no effect on the uptake of heat-
killed Synechococcus cells. It seems that ligands recognised by EPN on Synechococcus are very heat 
liable. This does not seem to carry over to S. enterica, which, at 100mM of GlcNAc, saw a significant 
decrease in dead cell uptake suggesting the S. enterica GlcNAc residue remained and are heat stable 
(Boboc, 2020) suggesting a different ligand. 
4.2.4.4. Interactions with scavenger receptors 
Scavenger receptors class A and B are the primary and best understood of the SR classes able to act as 
PRRs (Zani et al., 2015). Their activation allows for the non-opsonic phagocytosis of microbes and are 
common in mammalian phagocytes (Plüddemann et al., 2006; Plüddemann et al., 2011; Canton et al., 
2013). Class A (SR-A) is the primary macrophage SR class mediating non-opsonic phagocytosis (Zani et 
al., 2015). The main ligands of SR-A are LPS (specifically lipid A in LPS) from Gram-negative species 
(Hampton et al., 1991), lipoteichoic acid (LTA) from Gram-positive species (Dunne et al., 1994), and 
CpG bacterial DNA motifs (common bacterial immunostimulatory motifs) (Zhu et al., 2001). SR-A also 
binds various bacterial surface proteins, although these are more limited and less common targets (Peiser 
et al., 2002; Peiser et al., 2006). Although less is known about them, Class B (SR-B) ligands seem to be 
similar to SR-A, being primarily LTA (Hoebe et al., 2005; Stuart et al., 2005) and LPS (particularly rough 
LPS, i.e, lacking O-antigen) (Stuart et al., 2005; Biedroń et al., 2016; Olonisakin et al., 2016). Some 




SR-B members have been identified in the slime mold Dictyostelium discoideum (Lmp A and B, 
homologues of Limp-2 and CD36 respectively) (Sattler et al., 2018) and a Lmp B homologue is present in 
Tetrahymena (www.ciliate.org); although no published literature has made mention of it yet. Being a 
Gram-negative bacterium, Synechococcus possesses a simple, fairly well elucidated LPS layer which 
could indeed act as an SR-A/B ligand (Snyder et al., 2009). Their Gram-negative classification means 
Synechococcus does not possess traditional LTA, however, an unpublished PhD thesis did suggest it 
possesses a teichoic acid-like polysaccharide with a similar structure to the teichoic acids of Gram-
positive bacteria (Arnosti, 1993). Whether this could substitute as an LTA ligand is unknown. The thick 
peptidoglycan layer characteristic of Synechococcus (Hoiczyk and Hansel, 2000) is also a potential target 
for SR-Bs, although not as thick as in a traditional Gram-positive bacteria, it does provide other potential 
epitope. 
The data suggested SRs played a role in the uptake of live Synechococcus, however, this was lost upon 
heat-treatment, suggesting the SR ligand was heat liable. This provides evidence against the idea that LPS 
might be the primary SR ligand, as SR blockage when feeding on dead S. enterica has no effect on prey 
uptake or vacuole formation (Boboc, 2020), and S. enterica is a true Gram negative cell. This suggests 
either a secondary, yet unidentified, Synechococcus SR ligand (not found in S. enterica) is present or that 
the ‘semi-Gram-positive characteristics’ of Synechococcus (thick wall, teichoic acid like peptidoglycan) 
are the SR ligand(s). To confirm this SR, experiments should be repeated using a true Gram-positive 
species with well-defined SR ligand structures. 
4.3. The effect of CBD on T. pyriformis feeding 
T. pyriformis, feeding on live Synechococcus sp., was subjected to a dose response feeding experiment 
with CBD concentrations from 0-6 µM. The MIC for a reduced ingestion rate (IR) was >1.75≤2 µM and 
then, at >2.25≤2.5 µM, feeding stopped completely. This cessation in feeding was temporary and a 
positive correlation in its duration with CBD concentration was recorded. When the lag ended, feeding 
resumed and the IR was positively correlated to the duration of the feeding lag. A feeding lag of 32 min, 
induced hyperphagia in T. pyriformis.  
This suggests that one of the primary targets of CBD is to stop feeding completely and induce a lag, and 
then, possibly after the CBD is inactivated or degraded (mechanism still unknown), the subsequent IR is 
directly proportional to the length of that lag. The latter suggests that the post-lag feeding is directly 
related to the satiation level of the ciliate, as the cell would continue to defecate FVs during the lag 
period, so the length of the lag would determine the satiation level of the ciliate.  
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4.3.1. The CBD-induced feeding lag 
4.3.1.1. MIC and duration 
The MIC for a reduced IR was >1.75≤2 µM which is very close to the >1.50≤1.75 µM recorded by 
Jaisswar (2020) using the same T. pyriformis and Synechococcus strains. The cessation of feeding also 
occurred at a very similar CBD concentration (>2.25≤2.5 µM, current study; >2.20≤2.25 µM, Jaisswar, 
2020). The only discrepancy was that at 4 µM CBD the average lag duration in the current study was ca. 
40 min whereas Jaisswar (2020) recorded a duration of ca. 60 min. These slight discrepancies might be 
attributed to CBD age/potency, with an older stock being used for the earlier current experiments until a 
new stock was used for CBD + C-type lectin receptor experiments (Fig 3.7); where the lag duration was 
ca. 60 min.  
The MIC for the CBD-induced lag in T. pyriformis is higher than the  >0.1≤1.0 µM recorded for the 
amoeba V. vermiformis (Al-hammadi, 2020). Also, this amoeba only required 2 µM CBD to induce a 37 
min lag (duration was >100 min at 5 µM), showing that it is more sensitive to CBD than T. pyriformis.  
4.3.1.2. CBD targets for induction of feeding lag 
CBD is known to interact with at least 65 different molecular targets within the human body, with 10 of 
these targets being characterised receptors (Bih et al., 2015) T. pyriformis was therefore subjected to 
experiments whereby these receptors were blocked, prior to CBD treatment, then feeding on live 
Synechococcus sp. was determined after 5 min and compared to an untreated Control (with vehicle only).  
None of the blockers tested alleviated the CBD-induced lag period, and none (in the absence of CBD) 
affected IR which suggested they play no role in the T. pyriformis feeding mechanism. The GPCRs tested 
included those coupled to Gi/o or Gt (CB1, CB2, Dopamine D2, Adenosine A1, Serotonin 5-HT1A and 
Opioid [all forms]), and those coupled to Gs (GPR55, GPR119 and the two GPCRs in T. pyriformis [6 
and 31]). The non-GPCRs receptors included TRVP, 5-HT2A, all PPAR isoforms, Adenosine A2 and 
Dopamine D1.  
Results indicating the lack of involvement of CB1, CB2, TRVP, GPR55 and GPR119 in feeding (and 
then interacting with CBD) were to be expected as a de novo phylogenetic analysis strongly suggested 
that Tetrahymena does not possess them (McPartland et al., 2006). In addition, an Adenosine receptor has 
yet to been found in Tetrahymena even though adenosine is known to be used for metabolism of its 
phosphate linked derivatives (Voichick et al., 1973). Of the remining receptors, there is evidence of either 
their existence in Tetrahymena, or the existence of their agonists.  
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Tetrahymena has been reported to possess a dopamine D1-like receptor - but the authors also alluded to 
the possibility of a D2 like receptor (Ud-Daula et al., 2012). Dopamine is synthesised, stored and secreted 
by Tetrahymena although no effect on phagocytosis has been recorded to date (Csaba, 2015). Therefore, 
its lack of involvement in T. pyriformis phagocytosis in the current study might not be so surprising.  
Tetrahymena possesses an opioid receptor homologue which appears to be most similar to the µ (MOR) 
class of opioid receptors (Chiesa et al., 1993). Opioids, both exogenous and endogenous, can inhibit 
phagocytosis in Tetrahymena through a receptor mediated mechanism (Salaman et al., 1990; Renaud et 
al., 1995; Rodriguez et al., 2004), presumed to be via the identified opioid receptor (Chiesa et al., 1993). 
Even though CBD exhibits allosteric modulation of MOR in other cells (Vaysse et al., 1987; Kathmann et 
al., 2006), it did not appear to interact this receptor to cause the inhibited phagocytosis in T. pyriformis. 
Tetrahymena possesses two annotated GPCRs, 6 and 37, which are involved in chemo-attraction and 
chemo-repulsion, respectively (Lampert et al., 2011; Zou and Hennessey, 2017). Indeed, GPCRs have 
been previously shown to be involved in prey detection and taxis in the ciliates Paramecium and Stentor 
(Marino et al., 2001; Ondarza et al., 2003), so the lack of their involvement in the phagocytic process 
might not be surprising. Additionally, even though Lampert et al. are still annotating 7 remining putative 
GPCRs in T. thermophila, based on the current experiment’s blocking experiments (e.g. using Gallein, a 
blocker for all GPCRs), it is likely that these will also not be involved in phagocytosis.   
Tetrahymena is known to synthesize and respond to its own serotonin (Csaba, 2015) which increases 
phagocytosis (Quiñones-Maldonado and Renaud, 1987), and some evidence exists for the direct 
interactions of the cannabinoids with serotonin receptor subtypes (Russo et al., 2005; Gonca and Darıcı, 
2015; De Gregorio et al., 2019). However, a receptor has yet to be characterized in T. pyriformis, but if it 
is related to classical 5-HT receptors, results from the current study suggest that it is not involved in 
ciliate phagocytosis and does not interact with CBD. This contrasts with the study of Al-hammadi (2020) 
who found that the CBD-induced feeding lag in the amoeba Naegleria gruberi was abolished in the 
presence of (S)-WAY 100135 dihydrochloride which is a potent and selective 5-HT1A antagonist. This 
response appeared specific to N. gruberi as all the other amoeba genera tested did not respond to this 
blocker.   
Peroxisome proliferator activated receptors (PPARs) are not currently acknowledged to exist in 
Tetrahymena, via genome annotation, although their cells do contain peroxisomes (De Duve and 
Baudhuin, 1966; Fok and Allen, 1975). However, the existence of a single, promiscuous PPAR-like 
molecule (which can bind all isoform agonists) has been proposed to exist in both T. pyriformis 
(Wanlahbeh, 2020) and V. vermiformis (Al-hammadi 2020). Moreover, pre-blocking V. vermiformis with 
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a PPAR α antagonist eliminated the CBD-induced reduction in population growth (Al-hammadi, 2020), 
and the same PPAR α pre-blocking of T. pyriformis eliminated CBD-induced population death (blocking 
of all PPAR isoforms blocked AEA-induced population death) (Wanlahbeh, 2020). However, another 
study suggested that PPARs play no role in T. pyriformis feeding and the CBD-induced lag period could 
not be eliminated with the PPAR α blocker; which agrees with the current study. It therefore seems that 
CBD-induced effects on feeding and death in T. pyriformis are separate and PPARs are only involved in 
cell death.   
Two other receptors, with known CBD interaction, remain untested. Nicotinic acetylcholine receptor 
(nAchR) and Glycine receptors (GlyR) are both ligand gated ion channels exhibiting CBD interactions at 
physiologically relevant concentrations (Bih et al., 2015). No evidence for either receptor is present in 
protists, nor is there any suggestion that their natural ligands (glycine and choline/acetylcholine) affect 
ciliate phagocytosis in any way. Furthermore, members of the 4 primary families of PRRs (Toll-like 
receptors, CLRs, Nod-like receptors, and RIG-like receptors) are almost all metabotropic receptors (Jang 
et al., 2015). This makes it unlikely that the ionotropic nAchR and GlyR receptors, even if present, would 
be involved in ciliate feeding. It is difficult to advocate testing their involvement in the CBD-induced 
effect on T. pyriformis in the future, although they could be examined to make certain they are not 
involved (like all the other receptors tested).  
4.3.1.3. Ending the feeding lag  
A key feature of the lag period was that it was temporary, at the concentrations tested, suggesting that 
either the CBD naturally ‘wears off’ or is degraded within the cell. No study to date has evaluated the 
ability of T. pyriformis to metabolise CBD, which is unlike the situation for AEA, whereby two 
homologues of FAAH in T. pyriformis are known to hydrolyse this endocannabinoid (Karava et al., 2001; 
Karava et al., 2005).  
Mammalian studies indicate that the vast majority of CBD is excreted as mono/dihydroxylated derivatives 
or as glucuronide conjugates, with the enzymes responsible being CYP450 oxidases, glucuronyl 
transferases, or sulfotransferases (Ujváry and Hanuš, 2016). The author could find no evidence for 
Tetrahymena possessing glucuronyl transferases or sulfotransferases but analysis of available databases 
has suggested 102 CYP gene homologues are present in the T. thermophila genome. Three of these have 
been named as putative cytochrome CYP450s and all belong to the CYP13 family: CYP13A1, CYP13B1 
and CYP13A3 (www.ciliate.org).  
Cytochrome P450s are membrane bound, haem-containing, monooxygenases which are well-known for 
their role in the metabolism of both xenobiotics and endogenous compounds (Zendulka et al., 2016; 
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Manikandan and Nagini, 2018). At least 57 human CYP genes have been discovered, with 18 different 
families and 44 distinct subfamilies (Manikandan and Nagini, 2018). Despite this, the majority of hepatic 
xenobiotic metabolism is attributed to 6 members of families 1-3 (CYP1A2, 2C9, 2C19, 2D6, 2E1 and 
3A4) (Manikandan and Nagini, 2018). CYP-mediated CBD metabolism is mainly performed by 
CYP2C19 and CYP3A4 (Zendulka et al., 2016) although it is known that at least 7 CYPs (CYP1A1, 1A2, 
2C9, 2C19, 2D6, 3A4, 3A5) are capable of CBD metabolism (Jiang et al., 2011).  
Considering the CYP13 family is a member of the CYP3 clade (Yan and Cai, 2010), it is conceivable that 
the Tetrahymena CYPs (tCYP) might be responsible for CBD metabolism which leads to the end of the 
lag period. Further evidence comes from examining amoeba gene databases, and knowing that lag period 
duration is longer in V. vermiformis (Al-hammadi, 2020). Although data are not yet available for V. 
vermiformis, it appears that Acanthamoeba castellanii only has one putative CYP homologue, whilst 
Entamoeba spp. and Naegleria fowleri possess no CYP homologues at all; possibly suggesting that 
amoebae have less capacity to degrade CBD than T. pyriformis, hence the longer lags 
(www.amoebadb.org).  
A direct approach must be taken to compare the ability of amoeba and ciliates to metabolise CBD. Using 
labelled CBD and measuring rate of clearance from Tetrahymena sp. vs Entamoeba spp. or Naegleria 
fowleri (both of which have no CYP homologues) could indeed show whether possessing CYP 
homologues was correlated with a faster clearance rate. Radiolabeling of cannabinoids has long been used 
to test their interactions within the human body (Huestis, 2007) and could provide a way to quantify CBD 
concentrations (and thus clearance over time) between the two species. Alternatively, treating T. 
pyriformis with CYP inhibitors and observing the changes to the lag period afforded by CBD could 
confirm the role of CYPs in the metabolism of CBD in ciliates. If the lag were extended to become 
similar in length to that seen in amoeba sp. it would explain the species differences seen in lag phase 
length. 
4.3.2 T. pyriformis feeding post the CBD-induced lag period 
As stated previously, the post-lag IR is directly proportional to the duration of the lag period, suggesting 
that IR is directly related to the ‘fullness/emptiness’ of the ciliate; because cells would continue to 
defecate FVs during the lag period. Indeed, it is accepted that ‘starved’ protistan cells have higher IRs 
than their satiated counterparts (Boenigk et al., 2001b), which is corroborated by the post starvation 
hyperphagia seen in this study. These experiments employed T. pyriformis cultures that were 3 days old 
and as such, cells would be in stationary phase; they would be near starvation and not contain the 
maximum number of pre-existing FV at the start of the feeding experiment, i.e., maximum is 8 FVs/cell at 
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1 x 107 Synechococcus cells/ml (Jaisswar, 2020). Considering Jaisswar (2020) estimated that it takes T. 
pyriformis 12 mins to defecate a single Synechococcus-containing-FV at its cytoproct, a period of 32 
minutes would equate to the defecation of ca. 3 FVs, which seems to be the trigger for the cells ‘feeling 
starved’. Visual examination of the number of pre-formed FVs at the start of experiments (via DAPI 
staining) would have been useful to confirm this hypothesis. It is suggested they are performed in future 
experiments.  
The CBD dose-response experiments involved T. pyriformis feeding on live Synechococcus, which is now 
known to involve all three CLRs (for P/C and V/C) and SRs (for P/C only), so the potential interaction of 
these receptors with CBD was investigated. Pre-blocking T. pyriformis cells with mannose, GalNAc, 
GlcNAc or dextran sulphate did not themselves induce a feeding lag and their presence did not affect a 
CBD-induced lag period; so, the main CBD target remains at large (see 4.4). However, their presence did 
significantly reduce the CBD-induced hyperphagia but inspection of the data suggests that this is a 
‘mechanical’ response to the presence of the sugars, rather than being a specific interaction with CBD. 
For example, both mannose and GlcNAc reduced hyperphagic IR by 37% and GalNAc reduced it by 
46%. This reflects their natural blocking ability in the absence of CBD whereby mannose/GlcNAc 
reduced IR by 40-45% and GalNAc reduces it by 57%. So, the only reason why IR in cells treated with 
sugar + CBD are significantly higher than with sugar alone (Table 3.4), is that the former cells were 
‘emptier’ than the latter because the cells had experienced a feeding lag (with associated FV defecation).  
A previous study on the amoeba V. vermiformis feeding on live Synechococcus, also found that CBD did 
not directly interact with CLRs (Al-hammadi, 2020) and this was further confirmed in a feeding 
experiment using inert beads (that do not interact with CLRs), which showed an equivalent CBD-induced 
feeding lag duration to that recorded with live Synechococcus (Al-hammadi, 2020). She also suggested, as 
does the current study, that CBD bound to a yet unidentified target to induce the feeding lag and narrowed 
it down to possibly being an (unidentified) component within the signal cascade required for the 
activation of actin polymerisation for the formation of the phagocytic cup (see 4.4). In contrast, the CBD 
response in V. vermiformis was more complicated than that seen in T. pyriformis in that, after the CBD-
induced lag period, IRs in the amoebae were unexplainably lower than the Controls (compared to the 
relatively easy-to-explain hyperphagia seen in T. pyriformis) (Al-hammadi, 2020). This might be due to a 
reduced ability of amoeba to metabolise CBD, compared to ciliates, so as the CBD is slowly metabolized, 
the concentration falls below that which is able to induce a lag but remains at a concentration able to still 
reduce the IR (via phagocytic cup formation). Another possibility is that CBD has an alternative target in 
V. vermiformis and this might indeed be the case, as the CBD-induced lag period was completely 
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abolished in the presence of a PPARα antagonist whereas no effect of PPAR blocking was recorded in T. 
pyriformis. 
4.4 Potential cellular targets of CBD in T. pyriformis 
4.4.1 Targets involved in T. pyriformis feeding 
Based on the current study, it appears that the target for CBD in T. pyriformis is not involved with 
receptor-based prey capture (Fig. 4.1. stage 1), and based on Jaisswar (2020), it is also not involved in 
vacuole trafficking (Fig. 4.1. stages 3-5) and defecation (Fig. 4.1. stage 6). This leaves phagosome/food 





















Formation of a new FVs at the cytostome requires recycled FV membrane from the cytoproct (Fig. 4.1 
stages 7 and 8) and then the formation of a phagocytic cup, which then closes before the FV is released 
into the cytoplasm (Fig. 4.1., stage 2). Jaisswar (2020) considered it unlikely that FV closure and 
Figure 4.1. Simplified diagram representing the overall process of the ciliate phagocytic cycle. 1. Receptors available at the oral 
cavity (precise receptor location unknown) bind available prey filtered into the oral apparatus via ciliary beating. 2. Prey is swept down the 
cytopharynx into the cytostome where recycled membrane is used to form a food vacuole (FV) around the prey via the polymerisation of F-actin. 
3. Myosin activation and actin depolymerisation begins FV closure and dynactin activation facilitates scission of the FV from the cytostome. The 
Nascent FV then travels into the cytoplasm. 4. Nascent FV binds endosomes and lysosomes for FV maturation and digestion of prey 5. Mature FV 
is transported to cytoproct. 6. Indigestible particles are exocytosed via binding of FV membrane with membrane of cytoproct. 7. FV membrane is 
endocytosed from the cytoproct membrane and forms small disc-shaped vesicles. 8. Discoid vesicles are transported back to oral cytostome via a 
microtubule network and recycled for use in additional nascent FV synthesis. (Figure adapted from Al-Hammadi, 2020). 
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detachment were the targets for CBD because if they were, an unclosed vacuole would still be present at 
the base of the cytostome which could be filled with Synechococcus cells; and she never observed any 
accumulation of cells at the very base of the oral apparatus. However, the assumption that the vacuole 
could be filled with prey might be wrong, as CBD is thought to negatively affect cilia function (see 4.4.2) 
and this might have prevented the physical movement of prey down the oral cavity and into the awaiting 
FV (whether FV closure and detachment were affected by CBD or not). 
It is also considered that any downstream signaling cascades initiated by receptor-prey binding are not 
viable CBD targets, as blocking CLRs with their respective sugars would have halted these downstream 
signaling events and yet CBD still induced a feeding lag. In addition, because a CBD-induced feeding lag 
was obtained when T. pyriformis fed on inert beads, and these are considered to enter FVs via a non-
specific receptor-based route (Vogel et al., 1980) which is attributed to a ‘mechanical’ action of a cilia-
generated vortex only (Allen and Fokt, 2000; Grønlien et al., 2002), potential CBD targets associated with 
only the basal vacuole formation rate are sought. Future experiments might now be better placed in using 
beads as opposed to live Synechococcus, to identify the CBD target as this would provide less cellular 
‘complications’.   
Unfortunately for this study, there is very little in the literature on FV formation and membrane recycling 
in ciliates. However, ciliate cells have long been known to have a limited volume of membrane available 
for FV formation and hence the requirement for it to be recycled (Allen, 1974; Allen and Fok, 1980). 
Jaisswar (2020) estimated that 48-56 µm3 of membrane was available for FV manufacture T. pyriformis 
(total membrane volume unknown); no data on other species can be found by the author. It is suggested 
that a future experiment should employ confocal microscopy to assess whether FV recycling is affected 
by CBD. Confocal microscopy could also allow for live cell imaging, allowing visualisation of recycling 
in real time (Jensen, 2013). If recycling is halted, a collection of discoidal vesicles should be evident at 
the cytoproct. If these are absent, then it strongly suggests that they have been effectively transported to 
the cytostome and FV membrane recycling is not the target of CBD action.   
The recycling process begins with the fusion of the membrane from a ‘spent’ FVs with the plasma 
membrane at the cytoproct, then it is removed and deposited in the cytoplasm as small disk-shaped 
fractions which become flattened into discoidal vesicles (Allen and Fok, 1980). Within 3 minutes, these 
vesicles are coated with F-actin (Sugita et al., 2009) and become aligned to a bundle of microtubule 
ribbons, where they are then transported from the cytoproct to the cytostome in ca. 4 minutes (Allen and 
Fok, 1980). This is an example of ‘direct recycling’, i.e., no involvement of the lysosomal or Golgi 
systems on the vesicle’s journey back to the cytostome and has been shown to occur in Tetrahymena, 
Paramecium and Ophrydium (Allen and Fok, 1980; Goff and Stein, 1981; Grønlien et al., 2002).  
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Studies on ciliates have confirmed that actin plays a role in the formation of the phagocytic cup, migration 
of newly formed phagosomes into the cell, trafficking of phagosomes within the cell, and their fusion 
with lysosomes (Tiggemann and Plattner, 1981; Tiggemann et al., 1981; Allen and Fok, 1983; Méténier, 
1984). More recently, it has been shown to be involved in the first stage of FV membrane recycling, i.e., 
the retrieval of spent FV membrane from the plasma membrane, and in the coating of discoidal vesicles 
(Sugita et al., 2009). Considering actin is involved in the trafficking of food vacuoles, and this was a 
process not affected by CBD, it might suggest that this part of the membrane recycling process, and 
phagocytic cup formation, are not the targets for CBD in T. pyriformis.  
However, studies suggest that ciliates, including Tetrahymena, possess a repertoire of actin molecules and 
actin-related proteins (ARPs), each with different functions (Sehring et al., 2007a). Indeed, it is known 
that the actin isoforms on FVs change throughout their trafficking through the cytoplasm in Paramecium 
suggesting each has a specific role rather than having a general role (Sehring et al., 2007b). These 
isoforms also have varying sensitivities to antagonistic or agonistic drugs (Sehring et al., 2007a) which 
might possibly suggest that an actin isoform/ARP involved in one process (e.g. phagosome cup 
formation/closure/detachment) might interact with CBD, whilst another isoform involved with another 
process (e.g. FV trafficking) might not. However, the identity of the specific isoforms involved in 
phagocytic cup formation/closure/detachment, and the transport of discoidal vesicles along the 
microtubule network to the cytostome, is alluding the author due to the generic terms used in 
publications. For example, F-actin is considered to be involved in ‘vacuole synthesis’ in Paramecium and 
Tetrahymena (Cohen et al., 1984; Kersken et al., 1986) and, in Tetrahymena, genetic silencing of the 
ACT1 gene (which encodes the single essential gene for actin) ‘inhibits vacuole formation’ (Williams et 
al., 2006).  
Very recently, co-administration of Cannabichromene (CBC) with THC or CBD has been shown to cause 
disintegration of F-actin filaments inside urothelial carcinoma cells (Anis et al., 2021). Whether this was 
due to the CBC, or activation of CB1/2 activation is unknown, although use of a CB1/2 inverse agonist 
reduced the overall cytotoxic effects of the cannabinoids suggesting the latter played some role (Anis et 
al., 2021). No information could be found on the sole interaction of CBD with F-actin, making it hard to 
deduce whether it could act upon the actin in T. pyriformis.   
Microtubules play an important auxiliary role to actin in ciliate FV membrane recycling and ‘vacuole 
formation’ together with acting as a guide to maturing phagosome by facilitating their contact with 
incoming endosomes and lysosomes (Harrison and Grinstein, 2002). Microtubule ribbons are also present 
around the oral cavity and are responsible for the selective transport of endosomes, such as acidosomes, to 
newly formed food vacuoles (Schroeder et al., 1990). Tetrahymena possess 2 isotypes of β-tubulin and 1 
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isotype of α-tubulin but assembles 17 distinct types via distinct post translational modifications (PTMs) 
(Gaertig, 2000). Specific sub-populations are assigned to specific cellular locations depending on these 
defining PTMs (Wloga et al., 2008). For example, glutamylation of α-tubulin dictates localisation to cilia 
or the basal bodies, and are indirectly required for prey capture due to the requirement of the cilia in the 
filter feeding mechanism (Wloga et al., 2008). No information on the specific PTMs required for FV 
transport or recycling could be found. Microtubules and microfilaments in mammalian cells have been 
shown to be disrupted in a dose-dependent manner following treatment with CBD, THC and CBN (Tahir 
et al., 1992).  
In addition, the motor protein dynein, is also present in Tetrahymena, with at least 25 DHY genes being 
expressed (Wilkes et al., 2008). However, even though dyneins drive retrograde microtubule transport, 
they are more renowned for driving the beating of the cilia (see 4.4.2.1). Primary defects in dynein 
structure in the sensory and motile cilia in humans results in multiple ciliopathies, which share clinical 
features, such as mental retardation, cystic kidney, retinal defects and polydactyly (Lee and Gleeson, 
2011).  
4.4.2 Other cellular targets of CBD 
4.4.2.1. Cilia – movement and feeding 
Ciliate cilia are structurally and molecularly conserved within higher eukaryotes (Carvalho-Santos et al., 
2011). On their cell surface, the cilia are arranged in an array and they beat in a biphasic whip-like motion 
(Wood et al., 2007; Funfak et al., 2015). Motile cilia have a 9 + 2 microtubule pair ultrastructure, with 
inner and outer dynein arms (Fawcett and Porter, 1954; Lee and Gleeson, 2011). Dynein is essentially the 
microtubule molecular motor, which makes cilia move, and was first identified in the 1960’s (Gibbons, 
1963). It is unknown whether dynein is affected by CBD, but it is known that microtubules are (Tahir et 
al., 1992). In addition, Ca/CaM signalling is involved in controlling the stroke motion of ciliary beating in 
ciliates and cellular influx is controlled by voltage-gated calcium channels (VGCCs) (Tanida et al., 1986; 
Gonda et al., 2000; Lodh et al., 2016). CBD is known to inhibit human T-type VGCCs along with the 
non-selective cation channels TRPs, also known to regulate intracellular Ca2+ (Bih et al., 2015). Should 
CBD also target ciliary VGCCs in T. pyriformis, it could disrupt regular ciliary motility. Indeed, the very 
first report on ciliate interactions with cannabinoids did mention that, in addition to THC-induced delays 
in cell division, the treated T. pyriformis cells moved in a sluggish and irregular manner (McClean and 
Zimmerman, 1976). Such sluggish movement of T. pyriformis cells has also been observed in the 
presence of CBD (Parry, personal communication).  
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T. pyriformis is a classic filter feeder and as such, uses its cilia to direct prey into its oral cavity as it 
swims (Verni and Gualtieri, 1997; Caron et al., 2012; Geisen et al., 2018; Diaz and Laybourn-Parry, 
2019), thus a slower rate of swimming would mean fewer prey reaching the oral cavity. In addition, the 
oral cavity itself comprises an undulating membrane (UM) which is a line of kinetosomes (ciliary basal 
bodies), and 3 oral membranelles (short/stiffer cilia) (Smith, 1982). It is the beating of these 
membranelles, plus the cilia on the UM, that creates the mechanical currents that bring prey into the 
cavity from the external medium (Rasmussen, 1976; Smith, 1982). If these were also targeted by CBD 
then it is likely that no prey whatsoever would make it into, and through, the oral cavity to an awaiting 
FV. This might explain why, under CBD treatment, Jaisswar (2020) and the current author have never 
seen an accumulation of Synechococcus in the oral cavity during the CBD-induced lag phase. And it is 
interesting to note that when Tetrahymena was treated with an F-actin inhibitor (Cytochalasin B) it 
arrested food vacuole formation but the author did observe an accumulation of prey (carmine particles) in 
the oral cavity (Nilsson, 1977). Further work on cilia, particularly in the oral cavity, requires further 
investigation.  
4.4.2.2. Cell death and MAPK  
CBD appears to act more specifically on cancer cells than normal cells, by inducing apoptosis, and has 
thus been extensively investigated as a potential anti-cancer agent (Choipark et al., 2008; Shrivastava et 
al., 2011). Even so, CBD can also inhibit cell migration and proliferation in healthy cells (Pagano et al., 
2020). McClean and Zimmerman (1976) were the first to show that a ciliate (T. pyriformis) responded to 
a cannabinoid, i.e. THC, but cell death was not reported to have occurred. Instead, there was a delay in 
cell division (McClean and Zimmerman, 1976) which was predominantly in the G2 phase of the cell 
cycle (Zimmerman et al., 1981). More recently, Jones (2017) recorded T. pyriformis cell death in the 
presence of CBD (MIC 3.16 µM, IC50 4.38 µM) and Wanlahbeh (2020) showed that the population was 
able to recover from this death in ~90 minutes.   
 
Considering many of the current study’s experiments employed a standard CBD concentration of 4 µM, 
cells would have been dying during the experiment and feeding would have only been monitored in those 
surviving cells. It therefore begs the question as to whether the CBD-induced feeding response reported 
here is a side-effect of cell death. It is thought not. Firstly, Jones (2017) established the MIC for cell death 
as being 3.16µM yet, in the current study, a significant reduction in IR was observed at >1.75≤2 µM and 
the feeding lag began at 2.5 µM. These concentrations are below the MIC for cell death which shows that 
the action of CBD (at these concentrations) was independent of cell death. Secondly, Wanlahbeh (2020) 
reported that the blocking of PPAR α in T. pyriformis abolished CBD-induced cell death, yet Jaisswar 
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(2020) found that blocking this receptor had no effect on the CBD-induced feeding lag. Indeed, by 
blocking all PPAR isoforms with GW9662 in the current study, it was confirmed that PPARs play no role 
in CBD’s action on T. pyriformis feeding. It therefore seems that the CBD-induced effect on feeding and 
death in T. pyriformis are two separate processes and that PPAR is only involved in cell death.  
This demonstrates that the action of CBD on T. pyriformis might be more complicated than first thought 
and demonstrates the promiscuous behaviour it is renowned for. It is already known to be acting on two 
cellular processes in T. pyriformis (feeding and cell death), and possibly on cilia, but there may be others 
also. What was very interesting though, was the lack of involvement of a mitogen-activated protein kinase 
(MAPK) signaling pathway when CBD was applied to the cells.    
MAPK signalling cascades are a diverse set of signal transduction pathways that regulate various cellular 
functions including apoptosis, translation/transduction, proliferation and differentiation (Plotnikov et al., 
2011). At present, 4 MAPK pathways have been characterised in humans and named after the key MAPK 
in the pathway: Extracellular signal regulated kinase 1/2 (ERK 1/2), p38, cc-Jun N-terminal kinase (JNK) 
and ERK5 (Plotnikov et al., 2011). The former two pathways (ERK1/2 and p38) have been identified in 
Tetrahymena, and although not as well characterized as human MAPKs, the cells seem to utilise these 
signaling cascades in response to environmental stressors (Arslanyolu, 2006; 2007; Li et al., 2009; 
Arslanyolu and Yıldız, 2014).  
Annotation of the T. thermophila genome identified 11 MAPKs (TtMPK) of which 8 belonged to the 
ERK1/2, which are involved in abiotic stress responses (TtMPK 1-3 and 5-9) (Yıldız and Arslanyolu, 
2014). Only TtMPK 2 received further characterisation, displaying the closest sequence similarity with 
human ERK5, followed by the stress activated p38 MAPK (Arslanyolu and Yıldız, 2014). The p38 
MAPK pathway has been termed the ‘stress activated protein kinases’ (Nakashima et al., 1999) and 
responses to osmotic stress and decreases in temperature. In Tetrahymena, this response appear to be 
mediated by a MAPK-like protein sharing close sequence similarity to the mammalian p38 MAPK 
(Nakashima et al., 1999). Treatment of Tetrahymena with hydrogen peroxide has been found to induce an 
oxidative stress response (which arrests mitotic division) which can be abolished using the antagonists 
SB203580 (for p38) and PD98059 (for MEK) (Li et al., 2009). It is therefore surprising that T. pyriformis 
did not perceive the presence of CBD as an external stress in the current study, and that the CBD-induced 
lag was not alleviated with SB203580 (for p38) and PD98059 (for MEK); or indeed the other MAPK 
blockers. And, given the large range of CBD-interacting receptors in humans, a range of MAPKs will 
inevitably be responsible for transducing CBD signals in mammals (Hwang et al., 2017; Gugliandolo et 
al., 2020), and this ubiquity and diversity of function probably evolved to meet the complexity that 
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coincides with multicellularity. However, this is clearly not mimicked in Tetrahymena, as blocking these 
known CBD-interacting receptors, in the current study, also did not alleviate the CBD-induced feeding 
lag.  
On the one hand this could be viewed as the MAPK cascades of multicellular organisms being linked to 
CBD-interacting receptors (amongst many others) while the Tetrahymena MAPK system is likely to be 
much more limited in its coupled receptors and activating ligands. On the other hand, even though a 
CBD-induced feeding lag was not considered a stress response, the other CBD-induced mechanism of cell 
death might be, particularly since MAPK signalling cascades regulate various cellular functions including 
apoptosis (Plotnikov et al., 2011). Therefore, T. pyriformis survival experiments should be performed 
with all antagonists tested in the current study, to see if CBD-interacting receptors and MAPK pathways 























Chapter 5. Conclusion  
This study investigated the effects and molecular targets for CBD in T. pyriformis, which is known to 
possess a basic endocannabinoid system as well as the ability to react to exogenous phytocannabinoids. 
Results showed that CBD affected ciliate feeding on live Synechococcus cells in a dose dependent 
manner. The primary effect was a reduction in ingestion rate (IR) which ultimately led to a temporary 
cessation in feeding (the ‘feeding lag’); the duration of which was positively correlated to CBD 
concentration. Post-lag, the ciliate resumed feeding and IR was directly correlated to the duration of the 
lag period. This suggested that IR is related to the ‘fullness/emptiness’ of the ciliate at the end of the lag; 
because cells would continue to defecate FVs during the lag period (as food vacuole trafficking and 
defecation are unaffected by CBD). A lag period of 32 min (and defecation of ca. 3 food vacuoles) 
appeared to induce ‘starvation’ in T. pyriformis and this resulted in a significant increase in IR compared 
the un-treated Control (hyperphagia).   
The molecular target(s) mediating this CBD effect were deemed likely to be involved in T. pyriformis 
prey capture and/or vacuole recycling/food vacuole formation. With regards to prey capture, this study 
showed that live Synechococcus cells were ingested at higher rates than heat-killed cells and beads (which 
were equivalent), due to the fact that at least three CLRs (for mannose, GalNac and GlcNac ligands) and 
SRs were involved in their uptake. Heat-treatment appeared to destroy the mannose, GlcNAc and SR 
ligands on Synechococcus cells, leaving only GalNAc residues to facilitate the uptake of dead cells. None 
of the receptors tested were involved in the uptake of beads. The blocking of these receptors, with their 
corresponding sugar, prior to the addition of CBD did not abolish the CBD-induced feeding lag. 
However, post-lag IRs were not hyperphagic, but equivalent to what would be expected when blocking 
these receptors in the absence of CBD. This suggests that these receptors have no direct interaction with 
CBD. In addition to these receptors, further receptors (GPCRs and non-GPCRs) which are known to 
interact with CBD in other eukaryotic cells, were also blocked but none of them abolished the CBD-
induced feeding lag, suggesting that T. pyriformis has few, if any, CBD-interacting receptors. 
It may therefore be the case that the molecular target is indeed involved in vacuole formation/membrane 
recycling rather than prey capture. Such processes involve microtubules, which may be structurally 
disrupted by CBD, resulting in fewer viable filaments (Tahir et al., 1992). They also involve actin and 
dynein but it is currently unknown whether any of their isoforms can react to CBD. However, cilia also 
contain microtubules and dynein and in the presence of CBD T. pyriformis cells move in a sluggish 
manner. If cilia themselves are directly affected by CBD then ‘prey capture’ would be back in the frame 
as a CBD target because numerous cilia exist in the oral cavity of the ciliate, and the beating of these cilia 
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creates currents in the extracellular fluid which bring prey into the cavity. Without these currents, no prey 
would enter the oral cavity and be subsequently pushed down the ciliated cytopharynx and packaged into 
a food vacuoles. 
So, in this simple ciliate, CBD has already been shown to affect feeding and swimming, but there is 
another effect also (not studied here) whereby CBD can induce cell death in T. pyriformis and this 
involves PPARα (which is not involved in CBD-induced feeding lags). Whether any of the other CBD-
interacting receptors are involved in cell death remains to be seem, as it did seem strange that T. 
pyriformis did not consider CBD as an external stress and activate the MAPK pathway; as is seen in other 
eukaryotic cells.   
The fact that three responses to CBD (reduced feeding and swimming, and cell death) have been 
demonstrated in this simple ciliate suggests that the action of CBD on T. pyriformis is more complicated 
than first thought and demonstrates the promiscuous behaviour that CBD is renowned for in mammalian 
systems. However, whereas these latter cells contain a wealth of molecular targets for CBD, this study has 
shown that there does not appear to be too many in T. pyriformis, so elucidating which targets are the 
most important, and evolutionary conserved, might be achievable. Such information would help in the 
understanding as to why CBD is so promiscuous in multicellular organisms and by doing so, it is hoped 
that the knowledge gleaned will aid in the future implementation of CBD as an effective therapeutic agent 
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Stock Solution in 100mL of distilled water: 
NaCl – 2g 
KCl – 0.08g 
CaCl2 – 0.12g 
Add 5mL of stock solution to 995mL of distilled water. Resulting solution is to be autoclaved at 121oC 
for 20 minutes. 
Lysogeny broth (LB) agar. 
NaCl – 10g 
Tryptone – 10g 
Yeast Extract – 5g 
Agar No.2 – 15g 
Add to 1L of distilled water. Resulting solution is to be autoclaved at 121oC for 20 minutes. Once cool 
enough to handle the agar was poured into petri dishes under aseptic techniques. Once set, plates were 
stored at 4oC.  
Blue green 11 (BG 11) broth. 
Stock solutions A-H in 500mL of distilled water: 
Stock A: Sodium Nitrate (NaNO3) – 75 g 
Stock B: Dipotassium phosphate (K2HPO4) – 2g 
Stock C: Magnesium Sulphate Heptahydrate (MgSO47H2O) – 3.75g 
Stock D: Calcium Chloride Dihydrate (CaCl2.2H2O) – 1.8g 
Stock E: Citric acid – 0.3g 
Stock F: Ammonium ferric citrate green – 0.3g 
Stock G: EDTANa2 – 0.05g 
Stock H: Sodium Carbonate (Na2CO3) – 1g 
Stock solution I of trace metals in 1L of distilled water: 
Stock I: 
Boric Acid (H3BO3) – 2.86g 
Manganese Chloride Tetrahydrate (MnCl2.4H2O) – 1.81g 
Zinc Sulphate heptahydrate (ZnSO4.7H2O) – 0.22g 
Sodium Molybdate dihydrate (Na2MoO4.2H2O) – 0.39g 
Copper Sulphate Pentahydrate (CuSO4.5H2O) – 0.08g 
Cobalt Nitrate Hexahydrate (CO(NO3)2.6H2O) – 0.05g 
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Combine 10mL of stock solutions A-H and 1mL of stock solution I and make up to 1L using distilled 
water. Adjust pH to 7.1 using 1M Sodium hydroxide (NaOH) or Hydrochloric acid (HCl) and autoclave 
at 121oC for 20 minutes. 
5-(4,6-Dichlorotriazin-2-yl) aminofluorescein (DATF) staining solutions. 
Solution 1. 
Na2HPO4 – 0.71g 
NaCl – 0.85g 
Add to 100 mL of distilled water and autoclave at 121oC for 20 minutes. 
Solution 2. 
Tetrasodium pyrophosphate (Na4P2O7) – 0.89g 
NaCl – 0.85 g  
Add to 100 mL of distilled water and autoclave at 121oC for 20 minutes. 
Appendix 2. 
 
Evidence for Chosen Working Concentrations: 
Antagonist Working Concentration Reference  
GPCR Antagonists    
Gallein 10µM (Casey et al., 2010; Ukhanov et 
al., 2011) 
Pertussis toxin (PTX) 100ng/ml (Ondarza et al., 2003; Lampert 
et al., 2011) 
Melittin 0.3µM (Sommer et al., 2012) 
Non-GPCR Antagonists    
Capsazepine  10µM (Yamamura et al., 2004; Yang et 
al., 2019) 
GW9662 10µM (Shen et al., 2007; Wanlahbeh, 
2020; Jaisswar, 2020) 
ZM241385 10µM (Poucher et al., 1995) 
LE300 10µM (Kawamoto et al., 2012; Li et 
al., 2019) 
MAPK signalling components   
U0126 10µM (Ong et al., 2015; Wang et al., 
2018) 
PD98059 10µM (Kojima et al., 2007; Wang et 
al., 2017) 
SB203580 10µM (Li et al., 2009; Liu et al., 
2014b) 
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